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 Introduction 
1. INTRODUCTION 
 
“Intermediate filaments that may function to integrate mechanically, the various structures of the 
cytoplasmic space, in a way, that is tailored to the differentiated state of the cell” – Elias Lazarides, 
1980. One of the greatest challenges in this field is to unravel the cell type restricted function and 
regulation of the intermediate filament (IF) protein family 
 
1.1. Keratin genes  
 
Keratins are proteins which build the intermediate filament cytoskeleton of all epithelia. They are 
composed of two classes – 28 type I acidic keratins (K9-K28; epithelial keratins and K31-K40; hair 
keratins) and 26 type II basic keratins (K1-K8, K71-K74; epithelial keratins and K81-K86; hair keratins) 
encoded by two large gene families comprising >50 genes in the mouse and human (Schweizer et al., 
2006). Individual keratin genes are compact, spanning about 5-8 kb of DNA.  
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Fig.1.1. Type I keratin gene clusters of human (H), mouse (M) and rat (R). Sequence gaps in the rat keratin type I cluster are indicated 
by gaps and breaks in the corresponding sequence line. Keratin genes are marked by green triangles with the tip corresponding to the 3' 
end. Keratin genes are identified by the numbers used in the proposed nomenclature. For convenience, previously used numbers are 
added in parenthesis. Pseudogenes are marked by P. If available, cDNA accession numbers are provided. Accession numbers of EST 
sequences start with small letters.  The genes flanking the type I cluster are depicted as yellow triangles.  The approximate position of the 
multiple KAP genes interrupting the type I cluster is given. Conservation of synteny is indicated by the thin lines connecting corresponding 
human/mouse and mouse/rat genes, respectively. Numbers on these lines give the percent sequence identity at the protein level (modified 
from Hesse et al., 2004). 
  
 Unlike members of many other gene families, the type I and type II  keratin gene families are 
arranged in contiguous clusters  spanning 1.2 Mb on chromosome 11 and 0.68 Mb on chromosome 15, 
respectively, in the mouse  (Fig. 1.1 & 1.2). No other known open reading frames, except the hair-
- 1 - 
 Introduction 
specific high sulfur keratins, are contained in the two keratin gene clusters. All keratins are expressed in 
various combinations of at least one type I and one type II keratin from the 2-cell stage mouse embryo 
onwards in a tissue-specific fashion (Lu et al., 2005).  About half of the keratins are expressed in 
various, but highly specific combinations in simple and stratified epithelia. The other half are found in 
epithelial appendages including hair, nail, and others (Herrmann et al., 2003; Langbein et al., 1999; 
Langbein et al., 2001).  
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Fig.1.2. Type II keratin gene clusters of human (H), mouse (M) and rat (R). Sequence gaps in the mouse and rat clusters are indicated 
by gaps and breaks in the corresponding sequence lines. Keratin genes are marked by green triangles with the tip corresponding to the 3' 
end. Keratin genes are identified by the numbers used in the proposed nomenclature. For convenience, previously used numbers are 
added in parenthesis. Pseudogenes are marked by P. Flanking genes for the type II cluster are depicted as yellow triangles. When 
available, cDNA accession numbers are provided. Accession numbers of EST sequences start with small letters. The only type I keratin 
Ka18 (Krt18) gene at the end of the keratin II cluster is given in red. Conservation of synteny is indicated by the thin lines connecting 
corresponding human/mouse and mouse/rat genes respectively. A potential case of violation of synteny is depicted in red crossed lines.  
Numbers on these lines give the percent sequence identity on the protein level, except for the cases marked DNA (modified from Hesse et 
al., 2004).   
 
1.2. Keratin structure and organization within the cell 
 
All keratins share a tripartite domain structure, with the defining feature being a centrally 
located, 310-residue-long -helical domain containing long-range heptad repeats of hydrophobic/apolar 
residues (Fig. 1.3). This domain mediates coiled-coil dimer formation and represents the major driving 
force sustaining self-assembly (Fuchs et al., 1994; Herrmann and Aebi, 2004). The rod is flanked, at 
both ends, by non-helical sequences that differ in length, sequence, substructure, and properties. A "one 
gene/one protein" rule seems to prevail within the family, but for a few exceptions like lamin A/C, GFAP, 
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peripherin, and synemin which yield distinct protein products via alternative splicing (rev. Kim and 
Coulombe, 2007). 
Owing to the presence of long-range heptad repeats (Fig.1.3), type I and type II keratin proteins 
readily form highly stable coiled-coil dimers (10 nm in length), in which the two participating monomers 
exhibit a parallel, in-register alignment. Dimers then associate along their lateral surfaces, with an anti-
parallel orientation, to form apolar tetramers.  
Coil 1A 1B 2A                  2B                              
L1 L12            L2
PTMPTM
CaspCasp
TrS TrS
Head α-helical rod domain Tail
Type I
Type II
 
 
 
 
 
Fig.1.3. Schematic representation of the tripartite domain structure shared by type I and type II keratins. A central α-helical "rod" 
domain acts as the major determinant of self-assembly and is flanked by non-helical "head" and "tail" domains at the N and C termini, 
respectively. Within this 310-amino-acid-long rod domain, the heptad repeat-containing segments 1A, 1B, 2A, and 2B are interrupted at 
three conserved locations by linker sequences L1, L12, and L2. Rod domain boundaries consist of highly conserved 15- to 20-amino-acid 
regions (shown in brown) that are crucial for polymerization and are frequently mutated in human disease. The elements of biochemical 
regulation indicated include: the trigger sites (TrS) that mediate nucleation of keratin heterodimerization via coiled coil interactions; 
caspase-sensitive cleavage sites (Casp); and the major location of post-translational modifications (PTMs) (Modified from Magin TM).  
 
All keratins share the same domain organization. Despite a limited degree of sequence identity, 
which ranges from 50-90 % in each subfamily, any type I and type II protein can co-assemble into 
filaments in vitro (Hatzfeld and Franke, 1985). The greatest extent of sequence variability resides in the 
head and tail domains of keratins which are rich in Ser-Thr residues in simple epithelial and rich in Gly-
Gly-X in epidermal keratins. These domains are involved in specific protein interactions (Coulombe and 
Omary, 2002; Herrmann et al., 2003). 
 
N
N
N
N
 
 
 
 
 
 
Fig.1.4. Organization of keratin filaments via indirect immunofluorescence, in MCF-7 cells. Keratin IFs (green) are organized in a 
network that spans the whole cytoplasm, and are attached to desmosomes (red) at points of cell–cell contacts. N, nucleus. Scale bar, 10 
μm (Courtesy Dr. S. Loeffek and A.Wester).    
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Keratins are integrated with other key elements making up the cells’ interior. They interact with 
the other major determinants of cellular architecture, including microtubules, F-actin, and various types 
of adhesive complexes spanning the outer cell membrane, including desmosomal (cell–cell) 
attachments and integrin-based linkages to the extracellular matrix (Fuchs and Cleveland, 1998; Green 
and Jones, 1996; Jefferson et al., 2004 Garrod, 2002 #619; Svitkina et al., 1996) (Fig.1.4). The 
desmosome is an electron-dense complex found in tissues subjected to mechanical stress, such as 
stratified squamous epithelia cells and the myocardium. This intercellular junction is composed of a core 
region, which mediates tight cell-cell adhesion, and a plaque region, which mediates attachment to the 
intermediate filament cytoskeleton. The core region contains the extracellular domains of the 
desmosomal cadherins, the desmocollins and desmogleins. The cytoplasmic plaque region includes the 
C-terminal tails of the desmosomal cadherins, which associate directly and indirectly with various 
cytoplasmic proteins. The armadillo family proteins in the desmosome include plakoglobin and 
plakophilins. These proteins mediate interactions between the desmosomal cadherin tails,  
desmoplakin, a plakin family protein that binds directly to intermediate filaments and keratins. These 
components of the desmosome allow tethering of the intermediate filaments to the plasma membrane, 
thereby acting as a scaffold to provide structural integrity to cells and tissues (Fig.1.5). 
 
 
 
 
 
 
 
 
 
Fig.1.5. Structural organization of the desmosome. In the desmosome, desmogleins (Dsg) bind directly to plakoglobin (PG) and 
plakophilin (PP), which provide links to the N terminus (N) of desmoplakin (DP). DP also binds directly to the juxtamembrane domain of 
desmocollin-1a (Dsc). The DP C-terminal domain (C) interacts with intermediate filaments (IF). PP and DP co-cluster desmosomal 
components. PP binds IFs in vitro and associates with lateral keratin filaments in a DP N-terminal-dependent fashion in vivo. Modified from 
Hatsell and Cowin, 2001.  
 
1.3. Keratin expression 
 
All embryonic and adult internal epithelia express at least K8 and K18, which are complemented 
by keratins K7, K19, K20, K23, and others in many specialized epithelia. K8 and K18 are the first 
embryonic keratins, forming intermediate filaments from the 2-cell stage of mouse embryo (Fuchs and 
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Weber, 1994; Hashido et al., 1991; Herrmann et al., 2003; Lu et al., 2005). The basal layer of all 
stratified epithelia expresses K5, K14 and K15, which become replaced by other keratins, e.g., K1, K10, 
during terminal differentiation and by K6, K16 and K17 during wound healing and inflammation (Fuchs 
and Weber, 1994; Moll et al., 1982). Notably, there is a very significant variation in the amount of 
keratins per cell which might be of great importance for their function. Hepatocytes contain about 1%, 
whereas, epidermal keratinocytes contain up to 30 % keratin of their total protein content (Fuchs and 
Weber, 1994). The complex expression pattern has led to the hypothesis that keratin expression pairs 
have distinct functions. In support, keratins K5 and K14 form more stable protein complexes than K8 
and K18 in vitro in the presence of increasing concentrations of urea (Franke et al., 1983).   
 
1.3.1. Keratin expression during early embryogenesis 
 
K8 and K18 are the first IF proteins expressed during embryogenesis in the mouse. In pre-
implantation embryos, mRNAs coding for K7, K8, K18, and K19 are present.  However,  only K7 and K8 
accumulate as proteins, which are deposited in aggregates and not as filaments since their expression 
begins earlier than their filament forming counterpart,  K18 or K19 (Lu et al., 2005).  
 
 Tissue K7 K8 K18 K19 
E3.5 + + + + 
E6.5         
- trophoblast + + + + 
- visceral endoderm - + + - 
E9.5         
- yolk sac - + + - 
- trophoblast + + + + 
- amnion - + + + 
- embryo primitive gut + + + + 
 
 
 
 
 
 
 
 
- embryo surface  
  Ectoderm 
(+) + + + 
- embryo notochord (+) + + +  
 
Table.1.1. Expression of simple epithelial keratin proteins during early mouse development (modified from Lu et al., 2005)  
 
In late morula and blastocyst stages, K7 and K8 form short filaments with K18 in the 
trophectoderm and the inner cell mass (Brulet et al., 1985; Jackson et al., 1980; Lu et al., 2005; Oshima, 
1981; Paulin et al., 1980; Paulin, 1981). During later stages, K8 and K18, together with K7 and K19, are 
maintained in all simple epithelia of the embryo proper and in the single-layered surface ectoderm until 
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periderm formation, which starts at E12 in the mouse. Transcription of K8 and K18 becomes restricted 
to periderm cells, which are finally shed off during later developmental stages (Bickenbach et al., 1995).  
Thus K7, K8, K18, and K19 are regarded as the bona-fide embryonic and simple epithelial keratins (Bi 
et al., 2005). K5 protein expression starts in the forelimb surface ectoderm as early as E9.25, while the 
expression of its partner, K14, begins at E9.75. From E9.25 to E9.75, K5 forms atypical filaments with 
K18 in a subset of forelimb epithelial cells. Thus, it can be concluded that during preimplantation mouse 
development, keratins are preferentially expressed in the trophectodermal lineage. This extra-embryonic 
lineage forms the fetal–maternal interface within the placenta. Table 1.2 summarizes  keratin expression 
during early mouse embryogenesis.
 
1.4. The molecular basis of development of primitive endoderm derived yolk sac and extra-
embryo derived placenta  
 
1.4.1. The mouse yolk sac – the only pre-hepatic site for hematopoiesis 
 
Twenty four hours following formation of the blastocyst, two morphologically distinct populations 
from the inner cell mass (ICM) are established, one forming the epiblast which gives rise to the embryo, 
and the other to the primitive endoderm, which gives rise the extra-embryonic tissue, the yolk sac.    
However, the fate determination of the individual cells within the inner cell mass is highly debated. 
These inner cells are produced by two successive rounds of asymmetric division, first, during the 8- to 
16-cell transition and then during the 16- to 32-cell transition. Cells that express K8 within the ICM were 
found to be derived almost exclusively from secondary inner cells (Chisholm and Houliston, 1987).  
The primary function of the yolk sac epithelium is endocytic absorption of macromolecules from 
the uterine lumen and to maintain permeability barriers between the maternal (uterine) compartment 
and underlying fetal compartments (Jollie, 1990).  The intracellular junction between these endoderm 
cells consists of the typical zonulae occludentes, gap junctions, and desmosomes (King, 1982). An 
additional function of the yolk sac is its role as a haematopoietic stem cell niche.  
The yolk sac serves as the first site of hematopoiesis and vasculogenesis for supporting the 
developing embryo. It contains spontaneously developed blood islands, formed by clusters of 
hematopoietic cells surrounded by a layer of vascular endothelial cells at around E7.5. Primitive 
hematopoiesis is initiated by producing primitive, nucleated erythroblasts from unique erythroid 
progenitors, termed the EryP-CFC. These progenitors expand transiently in numbers within the yolk sac 
and are ultimately extinguished by E9.0 (McGrath and Palis, 2005).  Hematopoiesis moves on to other 
sites later on within the embryo proper as development proceeds (Baron, 2003). After E10.5, the intra-
- 6 - 
 Introduction 
embryonic mesoderm, at sites called the aorta-gonad-mesonephros (AGM), generates the first definitive 
hematopoietic stem cells (HSC) that eventually colonise the fetal liver (Dzierzak, 2003). The third source 
of HSC’s lies in the labyrinth region (discussed in section 1.4.2) at mid-gestation. These cells eventually 
mobilize into the fetal liver (Gekas et al., 2005; Ottersbach and Dzierzak, 2005).  
 
1.4.2. The mouse placenta 
The placenta begins to form at a time when the metabolic requirement of the growing mouse 
embryo approaches the capacity of the yolk sac. It is formed from the fusion of two tissues: the 
allantois, which is derived from extra-embryonic mesoderm and eventually develops into the umbilical 
cord, and the extra-embryonic chorion, which is derived from the polar trophectoderm overlying the 
inner cell mass of the blastula. The placenta mediates implantation and establishes the interface for 
nutrient and gas exchange between the maternal and fetal circulation.  Moreover, it initiates maternal 
recognition of pregnancy, alters the local immune environment and maternal cardiovascular and 
metabolic functions through the production of paracrine and endocrine hormones (Cross et al., 2002a). 
Abnormalities in any one of these functions can be associated with mild outcomes like intrauterine 
growth restriction to severe outcomes manifesting in implantation failure and embryonic, fetal or 
perinatal death. Studies of many mouse mutants with disrupted placental development indicate that 
signaling interactions between the placental trophoblast and embryonic cells have a key role in placental 
morphogenesis and embryonic development (Cross et al., 2002a). 
1.4.2.1. General anatomy and development of the mouse placenta 
 
The fetal placenta is composed of an outer epithelial layer derived from the trophectoderm and 
an inner vascular and stromal layer derived from the allantois (extra-embryonic mesoderm) (Cross et al., 
2002b). The trophoblast layer of the placenta arises from the first cell type to differentiate in the 
mammalian embryo — the outer trophectoderm layer of the blastocyst (Fig.1.6). By E3.5 of 
development, two distinct cell lineages are formed: the outer, specialized trophectodermal epithelium, 
which pumps fluid internally to form the blastocoelic cavity, and the inner cell mass (ICM). Around the 
time of implantation at E4.5, different trophoblast cell types begin to form. The trophectoderm cells 
overlying the ICM continues to proliferate and gives rise to the diploid extra-embryonic ectoderm and the 
ectoplacental cone of the early postimplantation conceptus (Copp, 1979) (Fig.1.6). The trophectoderm 
cells that are not adjacent to the ICM stop dividing but continue to endoreduplicate their DNA to form 
trophoblast giant cells. In the postimplantation embryo, more giant cells form from the outer regions of 
the ectoplacental cone and surround the entire conceptus. As development proceeds, the extra-
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embryonic ectoderm expands to form the chorionic epithelium, which is lined by a thin layer of 
mesothelial cells. The allantois arises from the mesoderm at the posterior end of the embryo and makes 
contact with the chorion at around E8.5. This event is termed chorioallantoic fusion, although no actual 
cell fusion takes place. After hours of allantoic attachment, folds appear in the chorion that marks the 
sites where feto-placental blood vessels grow in from the allantois to generate the fetal components of 
the placental vascular network. 
The trophoblast, with its associated fetal blood vessels, undergoes extensive villous branching 
to create a densely packed structure called the labyrinth. Coincident with the onset of morphogenetic 
branching, chorionic trophoblast cells begin to differentiate into two layers of syncytiotrophoblast cells 
that are in direct apposition to the endothelial cells of the fetal-derived blood vessels. An additional 
mononuclear cell type of unknown origin and function remains outside the syncytiotrophoblast layer 
(Rossant and Cross, 2001).  The trophoblast layer continues to specialize throughout gestation and, in 
general, fulfils two functions in every mammalian species. First, it generates the extensive surface area 
for nutrient exchange and provides the barrier between the maternal and fetal circulation. Second, 
trophoblast cells interact closely with the uterus and produce hormones that target maternal 
physiological systems and promote maternal blood flow to the implantation site. The trophoblast giant 
cells and spongiotrophoblast cells produce many specialized products like hormones [e.g. placental 
lactogens (Soares et al., 1996)], angiogenic factors [e.g. proliferin (Groskopf et al., 1997) and vascular 
endothelial growth factor (Achen et al., 1997; Vuorela et al., 1997)] and tissue re-modelling factors [e.g., 
matrix metalloproteinases (Teesalu et al., 1999) and urokinase type plasminogen activator (Teesalu et 
al., 1998)]. Hence, the mouse placenta behaves as a highly specialized unit that is supported by other 
cells involved in both its structure and function in fetal–maternal exchange. 
 
 
 
 
 
 
Fig.1.6. Placental development in the mouse.  Early development of the mouse embryo from embryonic day (E) 3.5–12.5, showing the 
origins of the extra-embryonic lineages and the components of the placenta. ICM, inner cell mass (Adapted from Rossant and Cross, 
2001). 
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1.4.2.2. Structures for transport functions in the mouse placenta 
Survival and growth of the fetus are critically dependent on the placenta. It forms the interface 
between the maternal and fetal circulation, facilitating metabolic and gas exchange as well as fetal 
waste disposal. In addition, the placenta produces hormones that alter maternal physiology during 
pregnancy and forms a barrier against the maternal immune system (Cross et al., 2003).  In humans 
and rodents, the fully developed placenta is composed of three major layers: the outer maternal layer, 
which includes decidual cells of the uterus as well as the maternal vasculature that brings blood to/from 
the implantation site; a middle “junctional” region, which attaches the fetal placenta to the uterus and 
contains fetoplacental (trophoblast) cells that invade the uterine wall and maternal vessels; and an inner 
layer, composed of highly branched villi that are designed for efficient nutrient exchange (Rossant and 
Cross, 2001). The villi are bathed by maternal blood and are composed of outer epithelial layers that are 
derived from the trophoblast cell lineage and an inner core of stromal cells and blood vessels. At E9.0, 
immediately after chorioallantoic fusion occurs, primary villi begin to develop, evenly spaced across the 
chorionic surface (Cross et al., 2003), and blood vessels soon fill in the villous folds (Rossant and 
Cross, 2001) (Fig.1.7). This vascular invasion of the chorion requires active participation of chorion 
trophoblast and allantoic mesoderm. The branchpoints are actively selected by clusters of chorion 
trophoblast cells which branch extensively into villi. 
 
 
 
 
 
 
 
 
Fig.1.7. Development of transport structures during mid-gestation mouse development. (a) Formation of placenta by fusion of the 
extra-embryonic mesoderm derived allantois and the extra-embryonic chorion. (b) The fetal vessels from allantoic mesoderm penetrate the 
chorion and invade the labyrinth. Syncytiotrophoblast (indicated in purple) forms around the developing fetal vessels. Maternal blood 
sinuses also enter the labyrinth and supply blood to the fetal vessels across the syncytiotrophoblast barrier. (c) Trophoblast cells fuse, 
forming syncytiotrophoblasts, and the three layers (allantoic mesoderm, interstitial syncytiotrophoblasts and chorion) come together to form 
the haemotrichorial labyrinth. Integration of fetal and maternal blood vessels within the labyrinth is critically dependent on the differentiation 
of the trophoblast stem cells to syncytiotrophoblasts (Modified from Rinkenberger and Werb, 2000).  
Nutrients are transferred across the placental barrier via several mechanisms, including passive 
diffusion, facilitated diffusion, and active transport (Doughty et al., 1996). A significant amount of solute 
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flux across the mouse placenta is achieved by passive diffusion (Sibley et al., 2004). Therefore, in 
addition to the overall surface area and permeability (Doughty et al., 1996), diffusional distance is a 
major factor influencing overall diffusional capacity of the placenta. In mice, a trilaminar layer of 
trophoblast cells separates the fetal capillary from the maternal sinusoids: a bilayer of 
syncytiotrophoblast surrounds the fetal blood vessel endothelium and a layer of mononuclear cells lines 
the maternal blood sinuses (Adamson et al., 2002) (Fig.1.8). Consequently the nutrients, gases, and 
waste must diffuse or be transported across four layers to get from one blood compartment to the next. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.1.8. Interaction between trilaminar trophoblast layer and blood spaces within the labyrinth. The trilaminar trophoblast layer 
consists of a bilayer of syncytiotrophoblast cells (layers II and III) that surround the fetal blood vessel endothelium and a mononuclear layer 
of trophoblast cells (layer I) that lines maternal blood sinusoids. Nutrients such as glucose must be transported through four cell layers to 
get from the maternal blood space into fetal blood vessels. Cx26 and GLUT1 have been shown to aid in the transport of glucose (Adapted 
from Watson and Cross, 2005). 
 
A common feature among most of the mouse mutants that die at mid-gestation is the reduced 
ability to transport nutrients, which results in fetal growth restriction or, under more serious 
circumstances, embryonic death. Most of these mutants have defects in the establishment or maturation 
of the placental villi, which in mice comprise the labyrinth layer. The labyrinth layer begins to develop at 
E9.0 and becomes larger and more extensively branched until birth (E18.5–19.5) (Adamson et al., 
2002). Maternal and fetal blood flows in a countercurrent manner within the labyrinth to maximize 
nutrient transport (Adamson et al., 2002). If the labyrinth is not appropriately vascularized with suitable 
patterning, branching, and dilation, placental perfusion is impaired. This results in poor oxygen and 
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nutrient diffusion (Pardi et al., 2002), eventually leading to embryonic lethality. When morphogenesis of 
the labyrinth is diminished, one of the most obvious differences is that the layer remains cell dense and 
there are fewer maternal and fetal blood spaces. There is strong evidence that the trophoblast cells, 
which are of epithelial origin, regulate fetal vascularization of the placenta. This comes from the 
observation that the receptors and/or signaling proteins of key signaling systems like Fgfr2, Met, Sos1, 
Mek1, Gab1 and Fzd2, are either exclusively expressed in the trophoblast compartment and/or their 
function is only required in the trophoblast compartment (rev. in Rossant and Cross, 2001).  Therefore, 
in the vast majority of labyrinth mutants, the differences are likely to be secondary effects, and only few 
mutants exist with primary vascular defects. Some of these mutants with a primary vascular defect 
includes vascular cell adhesion molecule, VCAM-1 (Kwee et al., 1995), connexin- 45 (Kruger et al., 
2000) and notch signaling genes (Fischer et al., 2004; Krebs et al., 2000). 
Given that keratins are expressed in all embryonic epithelial cells, one might expect phenotypes 
with altered embryonic and extra-embryonic development.  
 
1.5. Analysis of keratin function 
 
In a quest to analyse keratin function, a number approaches have been undertaken in the past. 
These include identification of keratin associated proteins, assessing properties of in vitro cultured cells 
transfected with mutant keratins and in vivo approaches (Coulombe and Omary, 2002; Herrmann et al., 
2003). The two former routes have led to limited success, since cell culture models presently available, 
in combination with a limited number of function-assessing assays, have not yielded appropriate 
conditions to study keratin function. On the other hand, mouse genetics has been most rewarding and 
has identified a vital role of keratins in certain epithelia. The analysis of these model systems carried out 
so far suggests that keratins have a major impact on cell architecture, cell size and proliferation 
depending on cell context but do not act as major regulators of epithelial differentiation. 
 
1.5.1. Knockout approaches 
 
Gene knockouts of 13 keratins analyzed so far has demonstrated phenotypes ranging from 
major defects causing embryonic lethality or skin fragility to subtle and late onset liver alterations 
(Coulombe and Omary, 2002; Herrmann et al., 2003). Deletions of K5 and of K14, both of which are 
expressed in basal epidermis, cause very extensive tissue fragility and perinatal death (Herrmann et al., 
2003). However, the deletion of K10, which is expressed in suprabasal epidermis and represents about 
30% of total epidermal protein, caused no structural defect. This is due to a compensatory effect from 
- 11 - 
 Introduction 
K14 which otherwise is normally restricted to basal cells. This suggested that at least some K10- 
specific functions are replaceable by K14. In older mice, however, the absence of K10 led to an 
increased basal cell proliferation and cell turnover in epidermis, probably caused by accelerated 
keratinocyte turnover via activated p38 MAPK (Reichelt et al., 2004). Furthermore, the authors also 
identified that keratinocyte proliferation was regulated by interaction of K10 with 14-3-3σ. Whether this 
results from K10-specific functions or from the lower amount of K14 versus K10, has not been resolved 
yet (Reichelt et al., 2001). The above experiments have established that the primary keratin function is 
to provide resilience against mechanical strain in basal epidermis and in the tongue epithelium, most 
likely, because these epithelial compartments are exposed to severe mechanical stress. This coincides 
with data from mutation analysis of patients suffering from point mutations in the corresponding keratin 
genes (Irvine and McLean, 1999). 
The function of keratins during embryonic development and in simple epithelia is less clear than 
in epidermis. All embryonic epithelia express at least the type I protein K18 and the type II protein K8, 
which are complemented by keratins K7, K19, K20, and K23 during the course of epithelial 
specialization (Hutton et al., 1998). Upon formation of the embryonic epidermis around E15, K8 and K18 
are sequentially replaced by K5 and K14, typical of the proliferative compartment of stratified epithelia. 
The functional significance of this expression change is not clear at present. It has recently been shown, 
that in embryonic K5 knockout mice, K8 is able to compensate for K5 until E14.5, the time at which K8 
expression ceases in the single-layered surface ectoderm (Lu et al., 2006). This suggests that an 
“embryonic” type keratin might be able to replace an epidermal one, if driven by an appropriate 
promoter. Mice deficient for K8 die from liver placental failure at E12.5 in the C57BL/6 strain of mice and 
display colonic hyperplasia in adult FVB/N mice (Baribault et al., 1994). The latter strain suffers from 
diarrhea, possibly resulting from the mislocalization of ion transporters in colonic epithelial cells (Toivola 
et al., 2004). Mice with a targeted deletion of either K18 or K19 develop normally, because these two 
keratins are co-expressed in embryonic epithelia. Hence they compensate for each other and form 
filaments with K8, although there is only a limited extent of sequence identity between K18 and K19 
(Magin et al., 1998). 
 
1.5.2. Keratin null mutants with mid-gestation phenotypes 
 
 Mice deficient for K8 die from placental failure at E12.5 in the C57BL/6 strain of mice. In order 
to clarify whether embryonic development requires keratins, the combined deletion of K18/K19 or of 
K8/K19 was carried out. As K18 and K19 represent the only type I keratins during early embryonic 
development, no filaments should form. In fact, all double-deficient mice died at E9.5 – E10 from 
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trophoblast fragility or from defects in the labyrinth layer formation, respectively (Hesse et al., 2000; 
Tamai et al., 2000). The K18/K19 double deficient embryos were accompanied by the deposition of 
K7/K8 aggregates in trophoblast cells, reminiscent of the deletion of the chaperone hsp40 which 
resulted in a similar keratin aggregate phenotype (Hunter et al., 1999). At this time of development, the 
embryo proper appeared normal in the absence of keratin filaments. This pathology was interpreted as 
a result of mechanical fragility by our lab, similar to keratinocyte fragility in EBS. Given the potential 
toxicity of K7/K8 aggregates in the K18/19 double-deficient embryos (Hesse et al., 2000), the precise 
function of keratins in development is still unclear and requires deletion of all 4 genes.  
 
Gene Comments References 
Type II K4 Compensation by K6 Ness et al., 1998 
 K5 K14 aggregates - gain of toxic function Bousquet et al., 2001 
 
K6a Total compensation by K6b 
Wojcik et al., 2000; Wojcik 
et al., 2001; Wong et al., 
2000 
 K8 
Phenotype stain dependent, 
compensation by K7 
Baribault et al., 1994; 
Baribault et al., 1993 
  
Type I K10 Compensation by K14 Reichelt et al., 2001 
 K14 Compensation by K15 Lloyd et al., 1995 
 K17 Compensation by K16 Wong et al., 2005 
 K18 K8 aggregates - gain of toxic function  Magin et al., 1998 
 K19 Compensation by K18 or K20 
Hesse et al., 2000; Tamai 
et al., 2000 
 K18K19 (double) 
Aggregates of K8 and K7, gain of toxic 
function Hesse et al., 2000 
 
Type I and Type II K19 K8 (double) Compensation by K7 and K18 Tamai et al., 2000 
 
Table.1.2. Compilation of keratin null mutations. A compilation of in vivo approaches that have been undertaken in order to 
characterize keratin function.   
 
Another interpretation for the trophoblast fragility and embryonic death was provided by Oshima 
and colleagues. They argued that the absence of keratin filaments rendered trophoblast giant cells more 
susceptible to maternal TNF which would trigger an apoptotic response. This was based on the finding 
that K8 and K18 can moderate apoptosis by sequestering TNFRI and TRADD (Oshima, 2002). It 
appears that the protective role of K8 and K18 in apoptosis is independent of them being soluble, 
aggregated or assembled into a cytoskeleton. Data to support the notion that K8 and K18 regulate 
apoptosis via sequestration of the c-Flip protein (caspase 8 homologue FLICE-inhibitory protein) has 
also been reported (Gilbert et al., 2004). However, this hypothesis is controversial since Ku et al., have 
assessed c-Flip expression in livers of K8 and K18 null mice and in transgenic mice that express K18 
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Arg89Cys or K18 Gly61Cys mutants (Ku and Omary, 2006). They were unable to detect alterations in c-
Flip levels in murine K8 null hepatocytes using two independent antibodies. Possibly, following death 
receptor stimulation, K8 may sequester the pro-apoptotic JNK thereby preventing JNK from 
phosphorylating pro-apoptotic nuclear transcription factor targets (He et al., 2002). 
Taken together, the data regarding specific keratin function in vivo are conflicting and cannot be 
resolved by targeting individual genes or pairs of them, due to redundancy. Therefore, knockouts of 
individual keratin genes suffered from a problem seen in many, if not all knockouts of other gene family 
members, namely compensatory upregulation/stabilization of other gene family members (Table 1.1). 
Also, the precise expression pattern of keratins is unclear, especially with regard to epithelial stem cells. 
An approach to circumvent these problems is genetic ablation of all keratin genes and their sequential 
replacement with individual genes.  
 
1.6. Large scale genome deletion approach 
 
In order to achieve genetic ablation of all keratin genes, a large scale genome deletion 
approach was undertaken in this thesis, which involved gene targeting in mouse ES cells and the Cre-
loxP system. It has previously been demonstrated that up to 10 Mb of the genome can be deleted 
without deleterious consequences (Zheng et al., 2000). The approach is based on two consecutive 
homologous recombination events, one at each end of the keratin cluster target locus in cis using two 
different targeting constructs followed by a Cre-mediated deletion of the keratin cluster. This approach is 
dealt with in detail in the chapter 2 “Aim and strategy”. 
This thesis, however, has focused on the deletion of the keratin type II cluster along with a single 
type I keratin, K18, by taking the following into consideration. 
• The keratin type II cluster contains at one end, the region coding for the type I keratin K18 (Hesse et 
al., 2001).  K8 and K18 are the first keratins to be expressed during embryonic development in mice 
(Fuchs and Weber, 1994). Hence, by deleting the type II cluster alone, one would abolish formation 
of keratin filaments as well as avoid aggregates of the early type I keratins thereby circumventing 
dominant negative effects of the aggregates, if any. 
• It has been reported that type II keratins precede type I keratins during early embryonic 
development (Lu et al., 2005). These results will identify the developmental stage and processes 
that rely on keratins and clarify whether protein aggregates or soluble keratins, if any, display 
important functions.  
- 14 - 
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2. AIM AND STRATEGY 
 
2.1. Aim  
 
Generation of large scale genomic deletions, followed by replacement of individual genes has 
been instrumental in understanding development of model organisms, e.g. Drosophila melanogaster. 
Using the keratin multigene family as a paradigm, the major aim of this project was to elucidate whether 
individual family members have exclusive functions in epithelia of the mouse. Keratins have comparable 
functions in different tissues.  The general function of keratin IF network is to endow epithelial cells with 
the mechanical resilience that they require to sustain incident mechanical stress and to aid in tissue 
repair following wounding (e.g. K6 and K17 in wound healing (Fuchs and Weber, 1994; Moll et al., 
1982). Apart from these structural functions, regulatory functions for keratin pairs have also been 
reported (e.g. protective role of K8 during TNF (Oshima, 2002) and Fas mediated apoptosis (Ku et al., 
2003), role of K8/K18 in c-Flip/ERK1/2 anti-apoptotic pathway (Gilbert et al., 2004) and K18 in 
metastasis (Fujii et al., 1988). This raises the question of functional significance of the multiplicity of 
keratin sequences. Is it that keratin genes have simply duplicated and diverged over evolution, but 
functionally the gene products are redundant? Or, did different keratin genes evolve to suit the particular 
functional needs of the tissues in which they are expressed? To begin to explore the answer to this 
fundamental issue of keratin biology, an approach to delete all type II keratins using the Cre/loxP based 
strategy was adopted.  Deleting all the type II keratins which are expressed earlier than the type I 
keratins(Lu et al., 2005), would lead to keratin null situation since many reports confirm that the type I 
keratins are rapidly degraded in the absence of its filament forming type II counterpart (Caulin et al., 
1997; Oshima, 2002).  
 
2.2. Strategy based on the Cre/loxP system 
 
The approach is based on two consecutive homologous recombination events, one at each end 
of the keratin cluster target locus in cis using two different targeting constructs followed by a Cre 
mediated deletion of the keratin cluster. However, for the restoration of the hprt function, the use of hprt-
deficient ES cells such as AB2.2 (Ramirez-Solis et al., 1995) or HM-1 (Magin et al., 1992) is required. 
Nevertheless, this is a method of choice given the number of ready-to-use targeting vectors for the hprt 
selection system available from the Mutagenic Insertion and Chromosome Engineering Resource 
(Adams et al., 2004) (MICER; http://www.sanger.ac.uk/micer), rather than the use of retroviral vectors to 
Aim and Strategy 
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target the second loxP site (Lindsay et al., 2001; Su et al., 2000; Yan et al., 2004), and the panel of 
rearranged chromosomes that has been engineered (Adams et al., 2004; Zheng et al., 1999b).  
 
2.2.1. Targeting constructs 
 
The first of the two constructs consists a neomycin resistance gene for gene targeting, a loxP 
site, a 5’-half-hprt (hypoxanthine phosphoribosyl transferase) minigene (non-functional hprt fragment) 
for chromosome engineering and about 4-10 kb genomic DNA homologous to one end of the keratin 
cluster (Fig. 2.1A). Similarly, the second constructs contains a puromycin resistance gene, a loxP site, a 
3’-half hprt minigene (non-functional hprt fragment) and about 4-10 kb genomic DNA homologous to the 
other end of the keratin cluster (Fig. 2.1B) (Ramirez-Solis et al., 1995). The constructs used for this 
purpose were isolated directly from genomic libraries of pre-made targeting vectors (Adams et al., 
2004).   The overall strategy is outlined in Fig.2.2. 
 
 
.  
 
 
 
 
 
 
Fig.2.1. Targeting constructs for the Cre/loxP mediated deletion of the keratin type II cluster.  A. 5’ hprt vector. B. 3’ hprt vector.  The 
genomic sequence homologous to the ends of the targeted locus are flanked by rare AscI sites to aid in changing of the orientation of the 
loxP site by one sub-cloning step if required. 
  
2.2.2. Homologous recombination 
 
All targeting vectors have been prepared from isogenic chromosomal DNA (AB2.2 ES cell line). 
After the first step of targeting into AB2.2 mouse ES cell line using one of the targeting vectors 
mentioned above, antibiotic resistant clones that are positive for the homologous recombination event 
would be used for the second targeting step. Double targeted clones would be isolated and confirmed 
for homologous recombination events (Ramirez-Solis et al., 1995).  
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Fig.2.2. The Cre/loxP based chromosome engineering strategy in cis. A. Targeting of the 5’ and 3’ hprt vectors to either end of keratin 
type II cluster in two steps in mouse embryonic stem cells. Both the loxP sites are targeted in same orientation. B. Cre mediated 
recombination between two loxP sites of double targeted clones in cis (on the same chromosome) leading to a deletion of the keratin 
cluster thereby rendering the clones neomycin and puromycin sensitive due to the loss of the Neo- and Puro-carrying reciprocal product 
but HAT resistant. 
 
 
 
 
 
 
 
 
 
 
Fig.2.3. The Cre/loxP based chromosome engineering strategy in trans. A. Targeting of the 5’ hprt vector to one end of keratin type II 
cluster B. Targeting of the 3’ hprt vector to the other end of the cluster on the homologous allele (trans). C. Cre mediated recombination 
between two loxP in trans (on two different chromosome homologues) leading to a deletion that is neomycin and puromycin sensitive as 
well as duplication that is neomycin and puromycin resistant. 
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At least 50% of the recombination events would have occurred on the same chromosome (cis) 
(Fig. 2.2). A cis recombination event between two loxP sites in the same orientation, in the presence of 
Cre recombinase, will lead to the deletion of the loxP flanked keratin cluster sequence in a circular 
molecule (Fig.2.2), whereas a trans recombination event will lead to deletions and duplication events 
(Fig.2.3).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2.4. Engineering a deletion and/or a duplication in embryonic stem cells (modified from Yu Y et al., 2001) I.  Targeting of the 5’ 
vector to the 5’ end of the keratin cluster.  II. Targeting of the 5’ vector to the 5’ end of the target locus.  Both cis and trans recombination 
events are shown.  III. Recombination products after Cre recombination in G1 and G2 phases of the cell cycle. In G2, four loxP sites are 
located on duplicated chromatids, and recombination events will result in various products. Drug selection will help with identifying the 
desired rearrangements.  
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Complex recombination products can arise when recombination takes place between sister 
chromatids and between the non-sister chromatids in the G2 phase of cell cycle (Fig.2.4). 
Recombination between the loxP sites in cis unites the two non-functional 5’- and 3’- hprt fragments and 
reconstitutes a functional hprt minigene. This provides a positive selection for this event when the ES 
cells are cultured in medium that contains hypoxanthine, aminopterin and thymidine (HAT). 
Recombination between the loxP sites in trans leads to a  mixture of those with the desired 
chromosomal deletion and with the undesired chromosomal duplication (Fig.2.3), which have been 
produced due to recombination events in the G1 and G2 phases of the cell cycle(Yu and Bradley, 2001).  
Since the distance of the two integration sites would be large, double labeled FISH using empty 
5’ and 3’ hprt vectors as probes would be used to identify double targeted clones in cis.   
 
2.2.3. Generation and analysis of mice lacking keratin type II cluster 
 
Chimeras generated by injecting the double targeted ES cells in cis into mouse blastocysts 
would yield progeny devoid of the keratin type II cluster in one allele by interbreeding the chimeras with 
wild type C57Bl6. The presence of coat color markers in targeting vectors, allows an easy discrimination 
of mice carrying the recombined chromosome (Zheng et al., 1999a). Inbreeding of these heterozygotes 
will yield progeny null for the keratin type II cluster. The resulting mutants can be analyzed for tissue 
fragility defects by histology, immunocytochemistry and electron microscopy. Given the mechanical and 
non-mechanical functions of keratins, particular focus of the analysis on the mice will be on the integrity 
of cells, proliferation, apoptosis, translational control and alteration in p38 signaling.  
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3. MATERIALS AND METHODS 
 
3.1. Materials 
 
 
3.1.1. Chemicals used 
 
 
Unless otherwise stated, chemicals were purchased from Serva (Heidelberg, Germany), Sigma 
(Deisenhofen, Germany), Roche (Basel, Switzerland), Fermentas (St.Leon-Rot, Germany), Merck 
(Darmstadt, Germany), Fluka (Deisenhofen, Germany), Invitrogen Life Technologies (Karlsruhe, 
Germany), or  Applichem (Darmstadt, Germany). 
All cell culture solutions, buffers, DNase I, antibiotics & normal goat serum were from Sigma 
(Deisenhofen, Germany), Invitrogen/Life technologies (Karlsruhe, Germany) & GibcoBRL (Karlsruhe).  
In vitro High Prime DNA labeling kit was from purchased from Roche (Basel, Switzerland).  
[α-32P]-dCTP was obtained from Amersham Biosciences (Buckinghamshire, UK). 
Restriction enzymes, protein and DNA markers dNTPs and NTP’s were from Fermentas (St.Leon-Rot, 
Germany). 
PCR reaction mix (Buffers, Taq polymerase enzyme, MgCl2), RT-PCR kit were purchased from 
Invitrogen/Life technologies (Karlsruhe, Germany).  
 
3.1.2. Ready-to-use solutions / reagents 
 
Acetic Acid 
Acrylamide solution (37.5:1) Acrylamide/Bisacrylamide for protein-SDS-gel 
Chloroform  
Colcemid 10 μg/ml (Roche, 295892), for Karyotyping of ES cells and for FISH 
DAB substrate (Biogenex, DC138R006) 
Dimethylsulfoxide (DMSO)  
ES-PBS- (Dulbecco’s Phosphate buffered saline) for ES cell culture 
Ethanol  
Ethidiumbromide, 10mg/ml  
Formaldehyde, 37 %  
Isopropanol  
Material and Methods 
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Mayer’s Hemalum Solution (Merck, 9249) 
M2 Medium (Sigma) for resuspending ES cells for blastocyst injection 
Methanol  
ProLong® Gold antifade reagent (Molecular Probes, P36930) 
Roti-Phenol TE equilibrated for purification of nucleic acids 
TEMED for protein-SDS gel 
Tissue-Tek OCT 
TRIzol for isolation of RNA 
Xylene 
Taq-Polymerase (Invitrogen, 10342-020) 
Tween-20 
Triton-X100 
DPX Mountant for histology (Fluka, 44581) 
 
3.1.3. Kits 
 
Biotin/Streptavidin system (BioGenex, HK340-9K) 
High Prime DNA labeling system (Roche, 11585584001) 
QIAEX II Gel Extraction Kit (Qiagen, 20021) 
Qiagen Plasmid Maxi kit (Qiagen, 12163) 
Qiagen Plasmid MIDI Kit (Qiagen, 12143) 
Superscript II Reverse Transcriptase (Invitrogen, 18064-014) 
 
3.1.4. Solutions for eukaryotic cell culture and blastocyst injections 
 
Name 
Final 
Concentration 
Constituents and their amounts 
ES WT 
Medium / 
Feeder 
Medium 
 
 
 
15% 
1mM 
2mM 
1x 
1:50000 
Was prepared by combining the following; 
500 ml Glasgow-MEM  
84 ml FCS, ES-culture pre-tested  
5.6 ml Na-pyruvate, 100 mM  
5.6 ml GlutamaxTM-1, 200 mM  
5.6 ml Non-essential aminoacids, 100x  
0.54 ml home made LIF 
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0.007% 0.91 ml Monothioglycerol  
Medium was stored at 4°C and used within a week.  
Gelatine 
stock 
 
1% Was prepared by adding 5 g Gelatine (G2500 swine skin Type I) to 
cell culture grade water and autoclaved twice.  0.1% working 
dilution was prepared in cell culture grade water.  The stock and 
working stock solutions were stored at 4° C.  
ES trypsin 
 
 
1 mM 
0.025% 
 
400 ml Cell culture grade PBS  
100 ml ES-EDTA-Solution  (1.85 g/l in cell culture grade water)   
5 ml Trypsin, 2.5%  
Solution was stored at -20° C and once thawed, it was stored at 4° 
C. 
ES freezing 
medium 
 
20% 
20% 
18.75 ml ES-WT Medium 
1.25 ml ES culture tested FCS  
5 ml Dimethylsulphoxide (DMSO) 
10x HEPES 
buffered 
saline (HBS 
buffer) 
 
 
20 mM 
2.5 M 
 
180 ml cell culture grade PBS 
16 g Sodium chloride  
0.74 g Potassium chloride 
0.252 g Disodium hydrogen phosphate 
10 g HEPES, 1 M  
240 μl Glucose, 100x  
pH was adjusted to 7.2 and the volume was adjusted to 200 ml.  
The solution was filtered through 0.1 μm pore filter and stored at -
20° C. To prepare 1x HBS, 10x HBS was diluted 10 times with 
sterile water which brings the pH to 7.05.  
Mitomycin C 
Stock 
2 mg/ml Mitomycin C stock of 2 mg/ml was prepared just before use, and 
feeder inactivation was performed at a concentration of 2 μg/ml. 
G418 Stock 100 mg/ml Stock was prepared by dissolving 1000 mg of G418 sulfate 
(Biochrom AG, A291-25) in 10ml cell culture grade water, filter 
sterilized, and stored at -20° C. Final concentration used was 350 
μg/ml. 
Puromycin 
Stock 
3 mg/ml Stock was prepared by dissolving 3 mg of puromycin 
dihydrochloride (Calbiochem, 540411) in 1 ml cell culture grade 
water, filter sterilized, and stored at -20° C. Final concentration 
used was 3 μg/ml. 
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HAT 1x  HAT Media Supplement (50x) Hybri-Max™. 1 vial was 
reconstituted with 10 ml sterile cell culture medium.  Final working 
concentration: 100 μM hypoxanthine, 0.4 μM aminopterin, 16 μM 
thymidine. 
Pregnant 
Mares Serum 
Gonadotropin 
(PMSG)  
Stock 
500 U/ml Intergonan for animals (Intervet, Germany). Stock was prepared by 
dissolving 1 aliquot of 1000 I.E (lyophilized powder) in 2 ml 0.9 % 
sodium chloride solution, aliquoted and stored at -80oC.  Final 
concentration used to induce superovulation in mice was 50 U/ml. 
Human 
Chorionic 
Gonadotropin 
(HCG) stock 
500 U/ml Predalon for animals (Organon, Germany). Stock was prepared by 
dissolving 1 aliquot of 5000 I.E (lyophilized powder) in 10 ml 0.9% 
sodium chloride solution, aliquoted and stored at -80oC.  Final 
concentration used to induce superovulation in mice was 50U/ml. 
 
 
3.1.5. Solutions for DNA Analysis 
 
Name 
Final 
Concentration 
Constituents and their amounts 
Sodium 
acetate 
3 M 40.82 g Sodium acetate in 100ml water. pH was adjusted to 5.2 with 
acetic acid and stored at room temperature. 
DNA loading 
buffer 
 
30% 
100 mM 
0.25% 
0.25% 
0.25% 
2% 
Ficoll Type 400 
3.72 g EDTA 
125 mg Bromphenolblue  
125 mg Xylenecyanol  
Orange G  
20% SDS  
Lysis buffer 
 
100 mM 
5 mM 
0.2% 
200 mM 
10 ml of 1 M Tris-HCl 
1 ml of 0.5 M EDTA  
1 ml SDS-solution, 20 %  
4 ml 5 M NaCl 
The above ingredients were added to 84ml of DNase/RNase free 
water and stored as 10ml aliquots at -20oC.  
10 x TBE 0.89 M 
0.89 M 
54 g  Tris-base 
27.5 g Boric acid 
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8 mM 20 ml from 0.5 M pH 8 EDTA  
The solution was autoclaved and stored at room temperature. 
20x SSC 
transfer 
buffer 
1.5 M 
0.5 M 
 
175.3 g NaCl  
88.2 g Sodium citrate 
pH was adjusted to 7.0 with a few drops of 10N NaOH solution.  The 
volume was adjusted to 1L and sterilized by autoclaving. 
DNA 
denaturation 
solution 
0.4 M 16 g NaOH in 1 L of water.  Stored at room temperature. 
Hybridization 
buffer 
50% 
5x 
5x 
1% 
0.1 mg/ml 
10% 
250 ml Formamid ultrapure 
125 ml 20x SSC 
5ml  100x Denhardt’s solution (Eppendorf, 0032007.155) 
25 ml  20% SDS  
5ml DNA, MB-grade; from fish sperm 10 mg/ml 
50 g Dextransulfate   
The contents were mixed and the volume was adjusted to 500 ml 
with sterile water, aliquoted and stored at -20oC. 
Proteinase K 
solution 
20 mg/ml 1 g Proteinase K (Applichem, A38300025) was added to 50 ml 
DNAase/RNAse free water, aliquoted and stored at -80°C.  
RNase 
Solution  
20 mg/ml 500 mg RNase was dissolved in 25 ml DD water and heated for 15 
min at 95oC.  Aliquoted and stored at -80oC. 
TBE (10 x) 900 mM 
900 mM 
25 mM 
109 g Tris-base  
55.6 g Boric acid  
0.93 g EDTA  
Dissolved in 1L water and pH adjusted to 8.3. 
TE buffer 
 
10 mM 
1 mM 
 
121 mg Tris  
37.2 mg EDTA  
Dissolved in 100 ml DD water, pH adjusted to 8.0 and sterilized by 
autoclaving.  Stored at RT. 
10x Nick 
translation 
(NT) buffer 
 
0.5 M 
50 mM 
0.5mg/l 
250 μl 2M Tris-HCl, pH 8.0 
50 μl 1M Magnesium Chloride 
0.5mg BSA 
Adjusted volume to 1ml and stored at –20oC. 
DNAse 1 mg/ml 3 mg DNAse I  
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solution 50% 
50% 
0.5 ml 0.3 M NaCl 
0.5 ml glycerol 
Stored at -20oC. 
dNTP’s for 
nick 
translation 
0.5 mM 
0.5 mM 
0.5 mM 
0.1 mM 
25 μl 2 mM dATP  
25 μl 2 mM dCTP 
25 μl 2 mM dGTP  
5 μl 2 mM dTTP  
Volume was adjusted to 100 μl with DNAase free water and stored at 
-20oC. 
β-
Mercaptoeth-
-anol 
0.1 M 69 μl of 14.4 M β-mercaptoethanol in 10 ml of DD water. Stored at 
4oC. 
Pepsin stock 
solution 
 
10% 1 g of pepsin dissolved in 10 ml of DD water. Stored at –20oC.  
Pepsin working dilution: 50 μl  pepsin stock solution was added to 70 
ml of DD water containing 700 μl of 1 M HCl.  
10x PBS 137 mM 
2.7 mM 
10 mM 
2 mM 
 
40 g NaCl 
1 g KCl 
89 g Na2HPO4.2H2O 
12 g KH2PO4  
Salts were dissolved in 4.5 L water, pH was adjusted to 7.4 with HCl, 
and volume was adjusted to 5 L with water and autoclaved.  Stored 
at RT. 
Magnesium 
chloride  
1 M 101.65 g MgCl2 in 500 ml water. 
PBS-
Magnesium 
Chloride 
0.25 M 5 ml 1 M Magnesium chloride 
95 ml 1x PBS 
Prepared fresh. 
Denaturation 
mix for FISH 
 
2x 
 
 
100 μl 20x SSC 
200  μl DNase/RNase free water 
700 μl de-ionised formamide 
pH was adjusted to 7.0 and prepared fresh. 
Washing 
solution for 
FISH 
4x 
0.2% 
 
140 ml 20x SSC  
1.4 ml Tween 20 
560 ml Distilled water 
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Blocking 
solution for 
FISH 
3% 0.09 g BSA 
3 ml 4x SSC/Tween 20 solution 
Detection 
solution for 
FISH 
 Blocking solution : Washing solution : : 1:2 
 
 
3.1.6. Solutions for Bacterial Cultures 
 
Name 
Final 
Concentration 
Constituents and their amounts 
Ampicillin 
solution 
5% 50 g ampicillin in 50 ml of water. Sterile filtered. End concentration 
used was 100 mg/ml.     
LB Agar 
 
 
2% 
 
1 L LB Medium 
32 g LB Agar in 1 L water 
Sterilized by autoclaving.  Antibiotics were added at 55°C and plates 
were poured. 
LB Medium  25 g LB medium was dissolved in 1 L water and sterilized by 
autoclaving. 
 
 
3.1.7. Solutions for Protein Biochemistry 
 
Name 
Final 
Concentration 
Constituents and their amounts 
5x Laemmli 
sample 
buffer 
 
50 mM 
5% 
40 mM 
5 mM 
5 mM 
20% 
0.01% 
Sodium phosphate pH 6.8 
SDS 
DTT 
EDTA 
EGTA 
Glycerol 
Bromophenol blue 
Solution was stored at -20oC and freeze/thawed not more than 5 
times. 
APS 10% 1g Ammonium persulphate in 10ml water. 
Stored at 4oC for not longer than 1 month. 
Stacking gel 0.5 M 15.1 g Tris-base 
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buffer (Upper 
Tris) 
 
0.4% 1 g SDS 
Volume made up to 250 ml after adjusting pH to 6.8, sterile filtered 
and stored at 4oC. 
Separating 
gel buffer 
(Lower Tris) 
1.5 M 
0.4% 
181.7 g Tris 
4 g SDS 
Volume made up to 1 L after adjusting to pH 8.8, sterile filtered and 
stored at 4oC. 
SDS-running 
buffer (1x 
Laemmli 
buffer) 
 
23 mM 
190 mM 
0.1% 
2.78 g Tris Base 
14.26 g Glycine 
5 ml 20% SDS stock  
The contents were mixed in 1 L water and pH was adjusted to 8.8.  
Stored at room temperature.  
Coomassie 
staining 
solution 
0.4% 
5 % 
40% 
 
1.0 g Coomassie Brilliant Blue G-250  
25 ml Acetic Acid  
200 ml Methanol  
Volume was adjusted to 500 ml with distilled water, filtered through a 
Whatmann filter paper and stored at room temperature. Solution was 
used more than once. 
Coomassie 
destaining 
solution 
 
10% 
30% 
50 ml Acetic Acid   
150 ml Methanol  
Solution made up to 500 ml with water. 
Ponceau S 
staining 
solution 
 
0.5% 
1% 
0.5 g Ponceau S 
1 ml Acetic acid 
Contents were dissolved in 100 ml distilled water and filtered; 
Solution was stored in dark at room temperature. 
Transfer 
buffer (1x 
Towbin 
buffer) 
25 mM 
192 mM 
0.1% 
10% 
3.028 g Tris 
14.41 g Glycine 
1 g SDS 
100 ml Methanol 
The contents were dissolved in 1 L water, and pH was adjusted to 
8.3.  Solution was stored at room temperature. 
10x  Tris 
buffered 
saline (TBS) 
0.1 M 
1.5 M 
12.1 g Tris 
87.6 g NaCl 
Contents were dissolved in 750 ml water, pH was adjusted to 7.5 
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and the volume was made up to 1 L. Solution was sterilized by 
autoclaving and stored at room temperature. 
Western 
washing 
buffer 
1x 
0.1% 
100 ml 10x TBS 
1 ml Tween 20 
Volume was made up to 1 L with water. 
Blocking 
solution 
5% 
1x 
0.5% 
5 g Skimmed milk (Sucofin) 
100 ml 10x TBS 
1 ml Tween 20  
Always prepared fresh. 
Alternative 
blocking 
solution 
5% 
1x 
0.5% 
5 g BSA fraction V  
100 ml 10x TBS 
1 ml Tween 20  
Always prepared fresh. 
Protease 
inhibitor 
1x Complete Protease Inhibitor Cocktail Tablets.  7 x stock solution was 
prepared by dissolving one tablet in 1.5 ml water, aliquoted and 
stored up to 6 months at -20°C.  
Phosphatase 
inhibitor 
1x Phosphatase Inhibitor Cocktail Tablets. 10 x stock solutions was 
prepared by dissolving one tablet in 1 ml water, aliquoted and stored 
up to 6 months at -20°C. 
 
 
3.1.8. Solutions for Histochemistry 
 
Name 
Final 
Concentration 
Constituents and their amounts 
20 % PFA 20% 
 
100 g paraformaldehyde 
1.9 ml 10 N NaOH 
DEPC water to 500 ml 
Solution was heated to 56oC until solution was almost clear, filtered 
through a Whatmann filter paper and stored as 10 ml or 50 ml 
aliquots at -20°C. The solution was diluted to 4% in 1x PBS before 
use.  
Eosin 1% 1 g in 100 ml of distilled water. Filtered and used for a maximum of 3 
weeks.  
Citrate buffer  0.1 M 
0.1 M 
10.5 g Citric acid in 500 ml water (Solution A) 
14.71 g Sodium citrate in 500 ml water (Solution B) 
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Before use, 9 ml of solution A and 41 ml of solution B was added to 
450 ml distilled water.  pH was adjusted to 6.0.  
EDTA buffer I mM 0.37 g EDTA 
1 L water 
Solution was adjusted to pH 8.0, autoclaved and stored at RT. 
Hydrogen 
peroxide 
1% (or 3%) 3.3 ml or (10 ml) of 30% Hydrogen peroxide   
100ml water. 
Prepared fresh. 
Washing 
solution 
(TBS-T) 
1x 
0.1% 
100 ml 10x TBS 
1ml Tween 20 
Volume was made up to 1L with water. 
Blocking 
solution 
5% 50 μl normal goat serum 
950 μl TBS-T 
Prepared fresh. 
 
 
3.1.9. Plasmids 
 
Name [size in base pairs] Description Reference  
3’ hprt vector [10654 bp] Targeting vector and FISH probe Adams DJ et al., 2004 
5’ hprt vector [9912 bp] Targeting vector and FISH probe Adams DJ et al., 2004 
MHPN117k13  [15915 bp]  
5’ hprt vector + insert homologous to 5’ 
end of keratin type II cluster 
Adams DJ et al., 2004 
cMHPN117k13 [14413 bp] 
Gapped insert of MHPN117k13 to aid 
in insertional targeting using NheI and 
BstBI followed by adding linkers to 
regain a NotI restriction site. 
This work 
MHPP332c09 [17586 bp]  
3’ hprt vector + insert homologous to 3’ 
end of keratin type II cluster. 
Adams DJ et al., 2004 
fMHPP332c09 [17586 bp] 
Insert flipped from MHPP332c09 in 
order to change orientation of loxP site. 
This work 
cfMHPP322c09 [16182 bp] 
Gapped insert of MHPN117k13 to aid 
in insertional targeting using SacI. 
This work 
Cre Pac [6000 bp] 
Expression of Cre in double targeted 
ES clones in cis. 
Taniguchi M et al., 1998 
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3.1.10. Primers 
 
Sense  5’ GAT AAC CGT ATT ACC GCC TTT G 3’ 
Antisense  5’ CGC CCT CTT GTC TAT ATC AAC C 3’ 
Product size : 2562 bp 
Primers used to identify homologous recombinants of 5’ end of keratin type II cluster targeting by PCR. 
Sense  5’ CCC AAG GTT AGC CAA TAA TAA CC 3’ 
Antisense  5’ AGC ACT TAT CTG ACC AAA TCC AG 3’ 
Product size : 397 bp 
Primers to prepare probes for Southern confirmation of 5’ end of keratin type II cluster targeted clones 
(BsrG1 fragment). 
Sense  BN 1007 5’ AGG GAA GAA AGC GAA AGG AG 3’ 
Antisense  BN 1008 5’ GCA GTT CCA GAC CTG ATG GT 3’ 
Product size : 2708 bp 
Primers used to identify homologous recombinants of 3’ end of keratin type II cluster targeting by PCR. 
Sense BN 1017 5’ GCC GAT GTC GTG TGA TAT TG 3’ 
Antisense  BN 1018 5’ TGC AGC TGG AGA CAC GTA AC 3’ 
Product size : 487 bp 
Primers to prepare probes for Southern confirmation of 3’ end of keratin type II cluster targeted clones 
(EcoRI fragment). 
Sense BN 1023 5’ GTG GGA CTC TGT AGG GAC CA 3’ 
Antisense BN 1024 5’ TGA ACC CAG GAG GTT GAG AC 3’ 
Product size: 826 bp 
Hprt primers to identify Cre mediated deletion in ES cells as well as in mice. 
Sense BN 5 5’ TGG GAC AGG AAG AGA GGT GAT C-3’ 
Antisense BN 159 5’ ACC AAA ACC AAA TCC ACT GCC G 3’ 
Product size: 1.8 Kb 
Primers to identify WT KtyII cluster allele – recognizes K5. 
Sense BN 1047 5' CAT TCT GCA CGC TTC AAA AG 3' 
Antisense BN 1048 5' GAT TCA GCC CCA GTC CAT TA 3' 
Product size: 616 bp 
Primers to prepare 5’ hprt probes to identify targeted and recombined loci. 
Sense BN 1049 5' AGG GCA AAG GAT GTG TTA CG 3' 
Antisense BN 1050 5' CCT GAC CAA GGA AAG CAA AG 3' 
Product size: 656 bp 
Primers to prepare 3’ hprt probes to identify targeted and recombined loci. 
Sense BN 1154 5’ ATC AAG GAT GCT CAT GC 3’ 
Antisense BN 1155 5’ TTC CGT CTC CAG ACA AC 3’ 
Product size: 184 bp 
Primers to identify mouse keratin 7 expression (RT-PCR). 
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Sense BN 1156 5’ TGC AGA ACA TGA GCA TTC 3’ 
Antisense BN 1157 5’ GGT GCG GCT GAA AGT GTT  3’ 
Product size: 158 bp 
Primers to identify mouse keratin 8 expression (RT-PCR). 
Sense BN 1158 5’ GAC GCT GAG ACC ACA CT 3’ 
Antisense BN 1159 5’ TCC ATC TGT GCC TTG TAT 3’ 
Product size: 137 bp 
Primers to identify mouse keratin 18 expression (RT-PCR). 
Sense BN 1160 5’ TAA GCA AGA CCG AAG TCA 3’ 
Antisense BN 1161 5’ CAC GCT CTG GAT CTG TGA  3’ 
Product size: 152 bp 
Primers to identify mouse keratin 19 expression (RT-PCR). 
Sense BN 1164 5’ ACC CAG AAG ACT GTG GGA TGG 3’ 
Antisense BN 1165 5’ GAG ACA ACC TGG TCC TCA G 3’ 
Product size: 300 bp 
Primers to identify mouse GAPDH expression (RT-PCR). 
 
 
3.1.11. Bacterial Strain 
 
Description Characteristics and Application Reference 
E. coli XL1-
blue MRF 
Genotype: recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 
lac [F´ proAB lacIqZΔM15 Tn10 (Tetr)] ; Amplification of 
plasmid  
Bullok et al., 1987 
(Bullock and Wright, 
1987) 
 
 
 
3.1.12. Mouse lines 
 
Genotype Short description Source 
C57BL/6 Wild type mice with black color for breeding and back crossing; 
females used as blastocyst donors for BCI.  
Charles River, 
Germany 
 
NMRI Wild type mice, albino; females were used as surrogate mothers 
and vasectomized males were used to create false pregnancies in 
the surrogate mothers. 
Charles River, 
Germany 
 
 
All mice were kept under the rule of the animal license: 50.203.2-BN 24, 20/04. 
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3.1.13. Eukaryotic cell line 
 
 
Description Characteristics and Application Reference 
AB 2.2 129S7/SvEvBrd-HPRTb-m2  - Hprt inactivated ES cells used 
for targeting loxP sites at either end of the keratin typeII 
cluster followed by generation of mice. 
(Ramirez-Solis et al., 
1995) – A gift from Prof. 
Allan Bradley 
Cos-7 Green African Monkey kidney cell line used to produce LIF. ATCC - CRL-1651  
 
3.1.14. Antibodies 
 
3.1.14.1. Primary antibodies 
Name Antigen Source Subclass Dilution/Application Source 
B A 0 3 0 0 
 
Biotinylated anti-
avidin D 
Goat  1/200 [FISH] Vector Labs 
1333062 Anti-DIG Mouse Monoclonal 
IgG1 
1/500 [FISH] Boehringer 
OVTL 12-
30 
K7 Mouse Monoclonal 
IgG1 
Undiluted [IF] Progen 
Troma 3 K19 Rat  Monoclonal 1/20 [IF] Baribault, 
Kemler 
Ks 18.04 K18 Mouse Monoclonal 
IgG1 
1/10-20 [IF] Progen 
Ks 8.07 K8 Mouse Monoclonal 
IgG1 
1/100 [IF] Progen 
Asp175 Cleaved caspase-
3 
Rabbit Polyclonal 1/500 [IF] 
1/200 [IHC] 
Cell signaling 
RR002 Anti-phospho-
Histone H3 
(Ser10) 
Mouse Monoclonal 
IgG 
1/1000 [IF] 
1/1000 [IHC] 
Upstate 
# 9212 p38 Rabbit Polyclonal 1/50 [IHC] 
1/1000 [IB] 
Cell Signaling 
# 9211 P-p38 Rabbit Monoclonal 1/50 [IHC] 
1/1000 [IB] 
Cell Signaling 
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3.1.14.2. Secondary / conjugated antibodies 
 
Name Anti- 
species 
Species Sub- 
class 
Dilution Application Source 
Cy2- 
Streptavidin 
   1/100 FISH Dianova 
Alexa 594 Mouse Goat IgG H+L 1/400 Immunofluoresence Molecular 
probes 
Alexa 488 Mouse Goat IgG H+L 1/400 Immunofluoresence Molecular 
probes 
Alexa 488 Rat Goat IgG H+L 1/400 Immunofluoresence Molecular 
probes 
Alexafluor 
488 
Phalloidin 
   1/40 Immunofluoresence Molecular 
Probes 
HRP Mouse Goat  1/30,000 Immuno blotting Molecular 
probes 
HRP Rabbit Goat  1/30,000 Immuno blotting Molecular 
probes 
 
 
3.1.15. General Lab Materials 
 
All sterile cell culture plastic-ware were purchased from Falcon, Sarstedt, Nunc and Becton Dickinson  
Pipette Tips and tubes were purchased from Sarstedt 
Fuji Medical X-Ray film (Fuji) 
High density photopaper  (Mitsubishi) 
Hybond-N- blotting membrane 30cm x 3m (Amersham, RPN303B) 
Microscope slides 76 x 26 mm (Engelbrecht) 
Protran Nitrocellulose Hybridization Transfer Membrane, 0.2 µm, 30 cm x 3 m Roll (Schleicher & 
Schuell) 
Sterile filters  0.45 μm, 0.2 μm, 0.1 μm (Schleicher & Schuell) 
SuperFrost® Plus microscope slides (Menzel #041300) 
Universal agarose  
Whatman 3mm-Paper GB 002 (Schleicher & Schuell #426693) 
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Whatmann filter paper (Schleicher & Schuell) 
Microspin G50 columns (Amersham, 27533001) 
 
3.1.16. Equipment and Materials used 
 
Instrument / Software Model / Version Company 
Agarose gel electrophoresis system B2; B1A Angewandte Genetechnologie 
AIDA software   Aida 2.11 Raytest 
Blotting Chamber Fast blot B49 Biometra 
Centrifuges 5417R, 5810R, 5417C Eppendorf 
CO2 incubator CB150; CB210 Binder 
Cryostat CM3050S Leica 
Film Developer  Curix 60 Agfa 
Fluoresence Microscope AxioPhot II Zeiss 
Incubators for bacterial cultures  Function line Heraeus Instruments 
Inverted tissue culture microscope Telaval 31 Zeiss 
Laminar flow system-type Herasafe Heraeus Instruments 
Microtome RM2155 Leica 
Microwave Vacuum Histoprocessor RHS-1 Milestone 
Paraffin embedding machine Tissue-Tek TEC Samura 
PCR-Thermocycler TGradient Biometra 
pH-Meter  761 Calimatic Knick 
Phosphorimager  ES 1000 Raytest 
Polytron Ultra-turrax T25 Janke & Kunkel 
Scintillation counter  Beckmann LS-6500 Beckmann 
Stereoscopic zoom microscope SMZ1500 Nikon 
Tissue drying oven TD066 Medite 
UV-spectrophotometer Genesys 10UV Thermoelectron corporation 
Vacuum Infiltration Processor Tissue-Tek VIP 5E-F2 Samura 
Water purifier Milli-Q Plus  Nanopure Barnstead 
Electroporator Gene Pulser II Biorad 
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3.2. Methods 
 
3.2.1. Routine culture, generation and characterization of genetically altered mouse embryonic 
(ES) cells 
 
AB2.2 ES cell line derived from Hprt-deficient 129s7/SvEBrd-Hprt b-m2 mice was used for all 
targeting experiments and generation of mice (Bradley et al., 1998).  This line was a gift from Dr. Alan 
Bradley.  These cells are grown on immortalized feeder cells, called snlp feeders (also a gift from Dr. 
Alan Bradley) which express G418 and puromycin resistance genes. 
For routine culture, AB2.2 ES cells were passaged twice a week, splitting them between 1:6 
and 1:12, depending on conditions. Medium was changed every other day as long as the culture was 
thin. At later stages, medium was changed every day.  
 
3.2.1.1. Thawing and plating cells 
 
Cell culture flasks were gelatinized by using enough 0.1% gelatine to completely cover the 
surface for at least 10 min.  The gelatine was aspirated off before plating cells. Appropriate amount of 
feeder cells (as per section 3.2.1.2) were plated together with ES cells or plated 3-4 h before. Feeder 
coated dishes could be used for up to 7-10 days. The integrity of the monolayer was checked before 
using them to plate ES cells. 
AB2.2 ES cells were thawed quickly in a 37°C bath and transferred into 10 ml pre-warmed ES 
cells medium. The cells were pelleted by centrifuging at 100 x g for 5 min. The medium was aspirated 
and replaced with 5 ml of fresh medium and re-plated on a feeder coated 25 cm2 flask. The cells were 
incubated at 37oC with 5% CO2.  Fresh medium was added to the cells on the following day. 
To subculture, medium was aspirated and cells were washed with 1 ml pre-warmed trypsin per 
25 cm2 flask (2ml per 75 cm2). Trypsin was removed and replaced with fresh trypsin and incubated at 
37°C incubator until cells dislodged by gentle agitation. 4 ml ES cell medium per 1 ml of trypsin was 
added and pipetted up and down against flask wall about 10 times to obtain a single cell suspension. 
The cells were pelleted by centrifugation for 5 min at 100 x g at RT.  The supernatant was aspirated and 
the pellet was re-suspended in medium. The cells were re-plated at desired density and in 10 ml 
medium for a 25 cm2 flask and in 30 ml for a 75 cm2 flask.  
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3.2.1.2. Inactivation of snlp feeder cells 
 
Mitomycin C treatment was used to inactivate feeder cells. 10 μg/ml mitomycin C was added to 
a confluent culture of feeder cells that were cultured in ES medium minus LIF and incubated at 37oC in 
5% CO2 for 3 h. The cells were washed 5x with pre-warmed PBS, collected by trypsinization and 
pelleted by centrifugation for 3 min at 100 x g at RT. The cells were resuspended in ES cell medium, 
counted, adjusted to an appropriate seeding density, e.g. 106cells/ml and frozen following the same 
regimen as described for ES cell freezing in section 3.2.1.5. For use in ES cell growth, feeders were 
plated on gelatine-coated dishes 1-2 h before plating ES cells at a density of 50,000 cells/cm2.   
 
3.2.1.3. Electroporation of ES cells  
 
All targeting experiments were carried out using a BioRad gene pulser and cuvettes of 0.4 cm 
electrode gap at a setting of 800 V, 3 microfarads using 200 μg of linearized column purified and 
phenol-chloroform extracted plasmid.  About 40 million ES cells were trypsinised and the cell number 
was determined using a counting chamber. Cells were resuspended in 0.8 ml of 1x HBS buffer and 
added to 200 μg linearized DNA, dissolved in 100 μl sterile TE in an Eppendorf tube and mixed by 
pipetting up and down using a 1 ml cell culture pipette. This was transferred into an electroporation 
cuvette. One pulse was applied and allowed to stand for 10 min. at RT. Cells were added to appropriate 
amount of medium and plated on feeder coated plates at about 2 x 106  cells per 10 cm dish in 10 ml of 
medium. Positive selection was started after 24 h. One plate did not receive any selection and served as 
a control to check cell recovery. Thereafter, medium was changed every day for about 8–10 days until 
visible antibiotic resistant colonies appeared. Colonies were isolated as described in ES cell colony 
isolation protocol (section 3.2.1.4), using 1/2 for PCR and leaving the remaining cells in a well of a 24 
well plate with approximately 1 ml of medium.  PCR and Southern positive clones for the homologous 
recombination event were expanded and frozen down as per section 3.2.1.5. 
 
3.2.1.4. Isolation of ES cell DNA for PCR-based genotyping 
 
About 100-400 colonies were tested for each targeting experiment. The colonies were picked 
along with approximately 150 µl of medium using a Gilson pipette tip. The colony was transferred to a 
well of a 24 well plate and dispersed by pipetting up and down 3-4 times. Half the cells were left in the 
plate and the other half was transferred into an Eppendorf tube for PCR analysis. 1 ml of selective 
medium with feeder was added to the wells and allowed to grow until 80% confluent. For PCR analysis 
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for homologous recombined clones, the cells were pelleted by centrifugation in Eppendorf tube for 2 min 
at full speed. The supernatant was aspirated off and 50 µl of 1x PCR buffer containing approximately 
0.5% of Triton X-100 for cell lysis and 200 µg/ml proteinase K was added.  The tubes were then vortex 
briefly and incubated for 1h at 65°C at slow motion on a rotating wheel. The cell lysates were heated for 
10 min at 95°C to inactivate proteinase K and then spun briefly.  5 µl of cell lysate was used for a 25 µl 
PCR reaction.  
 
3.2.1.5. Freezing of ES cells 
  
Cells from a confluent dish were trypsinized as mentioned in section 3.2.1.1, were counted and 
resuspended gently in   x ml of ES cell medium such that one aliquot of frozen cells contain about 2-4 x 
106 cells. x ml of 2 x freezing medium was added drop wise and mixed gently and transferred instantly 
to a Nalgene freezing container and frozen at -80°C overnight . Thereafter, cells were transferred to 
liquid nitrogen cell storage container.      
 
3.2.1.6. Karyotyping of ES cells 
 
Before any clone was used for further targeting or for blastocyst injections, the number of 
chromosomes was determined by karyotype analysis. A confluent 25 cm2 flask of ES cells was arrested 
in metaphase by incubating the cells for 1h at 37°C with 5% CO2 in 1 ml fresh medium containing 10 µl 
Colcemid solution.  Medium was removed and washed twice with PBS. 1ml of trypsin solution was 
added and incubated for 4 min at 37°C.  Activity of trypsin was arrested by adding 5 ml ES cell medium, 
and the cells were pelleted by centrifuging the cells at 100 x g for 10 min. Medium was removed and 1 
ml of 0.56% KCl was added drop wise to the cell pellet. The cells were gently resuspend by flicking the 
falcon tube and then another 4 ml of 0.56% KCl was added drop wise and mixed by flicking. The tube 
was incubated at 37oC for 8-10 min and once again the cells were pelleted by spin down gently at 60 x g 
for 5 min at RT.  Supernatant was discarded, pellet was loosened by flicking the tube and 2-3 ml of 
chilled fixative solution (methanol/acetic acid 3:1, freshly prepared) was added drop wise to the cells.  
The tube was incubate 5 min at room temperature and once again pelleted by spinning down gently for 
5 min at 60 x g. Supernatant was discarded. The fixation procedure was repeated once or twice and 
finally the pellet was resuspended in 0.5-1 ml fixation solution.  The solution was then dropped on clean 
glass slides, previously dipped in ice cold 45% acetic acid and allowed to spread for about 30 sec to a 
minute.  As the methanol disappeared from the surface and the cells became visible to the naked eye, 
the cells were briefly exposed to steam from a 70oC water bath for 1-3 sec, and then the slide was 
Material and Methods 
 
- 38 - 
quickly dried on a hot plate maintained at 70oC.  The slides were then incubate for 1 min in Giemsa 
staining solution (Giemsa stain, modified, 0.4%, Sigma), washed twice with distilled water, air-dried.  
The slides were mounted with DPX mounting medium.  The number of chromosomes in metaphase 
spreads of the nuclei were counted and checked for the required 40 chromosome number.   
 
3.2.1.7. Preparation of double targeted AB2.2 cells for blastocyst injections 
 
Cells were thawed 4 days before injection and passaged once. Medium was changed about 4h 
before cells were taken for injection.  Cells were trypsinized by first aspirating the medium, washing one 
time with 2 ml of trypsin and then by adding 3 ml of trypsin and incubating for 5-10 min at 37°C to 
receive single cell suspension. 5 ml of medium was added and pipetted up and down gently. Cells were 
pelleted by centrifugation for 5 min at 100 x g at RT, aspirating the medium and resuspending cells in 1 
ml of M2 medium.  All blastocyst injections and generation of chimeras were performed by Mrs. Rodica 
Maniu.   
 
3.2.2. Transformation 
XL1 blue competent cells were used to amplify the plasmid either in a sub-cloning step or prior 
to transfection.  The cell wall of this bacterial strain was permeabilized to accept the plasmid DNA by 
chilling them in the presence of divalent cations such as Ca2+. Cells were incubated on ice with the DNA 
and then briefly heat shocked by incubating them at 42oC for 90 sec followed by immediate incubation 
on ice for 90 sec.  During this time, the DNA enters the cell. The cells were allowed to recover by the 
addition of 400 μl of pre-warmed LB medium and incubating them at 37oC for 1h.  The cells were then 
spread on antibiotic resistant plates and the cultures were placed at 37oC o/n.  The following day, 
colonies were picked and processed for amplification of the plasmid after confirmation of the plasmid 
using restriction digestion.   
 
3.2.3. Plasmid Prep 
 
Amplification of plasmid was carried out either prior to a sub-cloning step or prior to transfection 
by using Qiagen MAXI kit and prepared according to the manufacturers’ protocol. 
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3.2.4. Polymerase Chain Reaction 
 
3.2.4.1. PCR to identify homologous recombinants from 5’ of keratin type II cluster targeting 
 
PCR conditions (5 μl DNA prep and 20 μl PCR master mix)   PCR programme 
 
2.5 μl 10x PCR buffer 
0.75 μl MgCl2 (50mM) 
1.0 μl 5mM dNTP’s 
1.0 μl typeII fwd1a sense primer 
1.0 μl typeII15’rev1 anti-sense primer 
0.2 μl (IU) Taq polymerase 
13.55 μl water  
 
Product size: 2562 bp 
 
3.2.4.2. PCR to identify homologous recombinants from 3’ of keratin type II cluster targeting 
 
PCR conditions (5 μl DNA prep and 20 μl PCR master mix)   PCR programme 
 
2.5 μl 10x PCR buffer 
0.75 μl MgCl2 (50mM) 
1.0 μl 5mM dNTP’s 
1.0 μl BN1007 sense primer 
1.0 μl BN1008 anti-sense primer 
0.2 μl (IU)Taq polymerase 
13.55 μl water  
 
Product size: 2708 bp 
 
 
 
Step Temperature Time Cycles 
1 95oC 2 min 1 
2 95oC 30 sec 
3 60oC 30 sec 
4 72oC 2 min 30 sec 
35 
5 72oC 5 min 1 
6 4oC ∞ 1 
Step Temperature Time Cycles 
1 95oC 2 min 1 
2 95oC 30 sec 
3 60oC 30 sec 
4 72oC 2 min 45 sec 
35 
5 72oC 5 min 1 
6 4oC ∞ 1 
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3.2.4.3. PCR to identify WT allele in ES cells as well as in mice (Identifies K5 locus) 
 
PCR conditions (1 μl DNA prep and 24 μl PCR master mix)   PCR programme 
 
2.5 μl 10x PCR buffer 
0.75 μl MgCl2 (50mM) 
1.0 μl 5mM dNTP’s 
1.0 μl BN6 sense primer 
1.0 μl BN189 anti-sense primer 
0.2 μl (IU) Taq polymerase 
17.55 μl water  
 
Product size: 1.8 Kb 
 
 
3.2.4.4. PCR to identify deleted cluster in ES cells as well as in mice (Identifies the HPRT gene 
after Cre-mediated recombination) 
 
PCR conditions (1 μl DNA prep and 24 μl PCR master mix)   PCR programme 
 
2.5 μl 10x PCR buffer 
0.75 μl MgCl2 (50mM) 
1.0 μl 5mM dNTP’s 
1.0 μl BN1007 sense primer 
1.0 μl BN1008 anti-sense primer 
0.2 μl (IU) Taq polymerase 
17.55 μl water  
 
Product size: 826 bp 
 
 
 
Step Temperature Time Cycles 
1 95oC 5 min 1 
2 95oC 30 sec 
3 66oC 30 sec 
4 72oC 2min  
35 
5 72oC 10 min 1 
6 4oC ∞ 1 
Step Temperature Time Cycles 
1 95oC 2 min 1 
2 95oC 30 sec 
3 60oC 30 sec 
4 72oC 50 sec 
35 
5 72oC 5 min 1 
6 4oC ∞ 1 
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3.2.4.5. RT-PCR of simple epithelial keratins and GAPDH from mouse embryo 
 
PCR conditions (1 μl cDNA prep and 24 μl PCR master mix)   PCR programme 
 
2.5 μl 10x PCR buffer 
0.75 μl MgCl2 (50mM) 
1.0 μl 5mM dNTP’s 
1.0 μl BN sense primer (listed in 3.1.10) 
1.0 μl BN anti-sense primer (listed in 
3.1.10) 
0.2 μl (IU)Taq polymerase 
17.55 μl water  
 
Product size: listed in section 3.1.10. 
 
3.2.5. Processing of nucleic acids 
 
3.2.5.1. Analysis of targeting constructs 
 
Restriction analysis served for the identification of targeting constructs that were received from 
Sanger Institute, for flipping of insert in order to change the orientation of the loxP site, for generating 
gaps in insert to aid in insertional targeting and for linearization of the plasmid prior to targeting. 
Following restriction analysis, the plasmid was analysed by performing agarose gel electrophoresis and 
visualizing the DNA fragments using ethidium bromide.  
 
3.2.5.2. Southern Analysis 
 
In order to identify correctly targeted ES clones, Southern analysis was carried out.  Here, about 
10 μg pre-digested genomic DNA (prepared as detailed in section 3.2.1.4) from PCR positive ES clones 
was separated on a 0.7% TBE-agarose gel for 450 volt hours.  The DNA was then denatured using 
0.4N NaOH and then the nucleic acids were transferred onto a positively charged nylon membrane 
using capillary transfer.  The membrane was then dried and baked for 2h at 80oC.  A DNA fragment 
encoding the gap region in the targeting construct was labelled with [α-32P]dCTP using High Prime 
Step Temperature Time Cycles 
1 95oC 2 min 1 
2 95oC 30 sec 
3 60oC 30 sec 
4 72oC 30 sec 
20/25/35 
5 72oC 5 min 1 
6 4oC ∞ 1 
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labelling kit (Roche) and was used as a probe. The nylon membranes were pre-hybridized at 42oC for 3 
hours in pre-hybridization solution and the membrane was then hybridized in the same solution 
containing the α-32P labelled probe at 42oC for 20 – 24 hours.  The membrane was then washed three 
times at 68oC for 20 min each in 0.1x SSC containing 0.1% SDS and subjected to autoradiography.  In 
case of confirming Cre mediated deletion of the keratin type II cluster in ES clones, a DNA fragment 
spanning the 5’ and 3’ regions of the human HPRT gene from the targeting construct were used as  
probes and labelled and processed similarly as above.   
 
3.2.5.3. Fluorescent in-situ hybridization  
 
Double targeted ES clones in trans will give rise to a deletion and duplication product on Cre 
expression, while in cis will yield only a deletion product (Fig.2.2 and 2.3). In order to identify if the 
double targeted ES clones were in cis or trans, fluorescent in-situ habitation was employed.   
Metaphase chromosome spreads from ES cells were prepared similar to karyotyping of ES cells 
outlined in section 3.2.1.6, and stopped where the slides were dried at 70oC.  The region with good 
metaphase chromosomes were marked using a diamond pen and the slides were fixed at 65oC, 
overnight.   
Empty 3’ HPRT and 5’ HPRT vectors were biotin and DIG labeled respectively by nick 
translation as follows.  Working dilution of DNAse I was determined beforehand as follows.  1 μl of 
DNAse I (1 mg/ml) stock solution was diluted to 1ml with ice-cold water immediately before use.  A 
series of digestions with 2 μg of probe DNA was carried out using 10 μl of 10x  buffer, 10 μl of b-
mercaptoethanol, and 1 μl, 2 μl, 5 μl and 10 μl of the DNAse I dilution respectively in a 100 μl reaction 
volume.  The reaction was incubated for 2h at 15oC.  Thereafter, aliquots of 5-10 μl were loaded on a 
1% agarose gel and size of the digested DNA was determined using a 1Kb ladder. The volume of 
DNAse that results in probe fragments of 100-500nt in length was chosen for the nick translation 
reaction.  
 
Labeling of probes by nick translation 
 
Labeling 3’ HPRT probe 
X μl DNA containing 2μg DNA   10 μl 10x NT buffer 
10 μl 0.1M β-Mercaptoethanol   10 μl dNTP’s  
2 μl Biotin dUTP    X μl DNAse (diluted 1:100 fresh) 
2 μl DNA polymerase    Volume made up to 100 μl with sigma wate 
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Labeling 5’ HPRT probe 
X μl DNA containing 2μg DNA   10 μl 10x NT buffer 
10 μl 0.1M β-Mercaptoethanol   10 μl dNTP’s  
2 μl Digoxigenin dUTP    X μl DNAse (diluted 1:100 fresh) 
2 μl DNA polymerase    Volume made up to 100 μl with sigma water 
 
The reaction was incubated for 2h at 15oC and the size of the fragments was determined by 
running a small aliquot on a 1% agarose gel.  The reaction was stopped by adding 3 μl of 0.5M EDTA 
and 0.5 μl of 20% SDS.  The labeled probe was purified using G50 Sepahadex columns (Amersham 
Biosciences, UK).  The probe was precipitated by combining 200ng of biotin labeled DNA, 200ng of 
digoxigenin labeled DNA (~15 μl if yield was good), 1 μl Salmon sperm DNA (10 mg/ml), 1/10th volume 
3M sodium acetate and 2.5 volumes of 100% chilled ethanol (-20oC) and incubating at -80oC for 30 min.  
The probe was pelleted by centrifugation at 14,000 rpm for 30 min at 4oC and washing once using 70% 
ethanol.  The pellet was air dried and to it 6μl of de-ionized formamide was added and mixed in a 
shaking block for 1h at 37oC followed by an addition of 6μl hybridization solution and additional 15 
minute incubation at 37oC without shaking.   
In the meantime, the slides were pretreated with 0.005% pepsin/0.01 M HCl , post fixed by 
incubating the slides in PBS-Magnesium chloride containing 3% of  37% formaldehyde for 5 min at room 
temperature and finally dehydrated  in ethanol series (70%, 90%, 100%) and air dried.  Once the slides 
were dry, 100 μl of pre-warmed (75oC) denaturation mix was placed on the area of the slide marked 
with good metaphase chromosomes, a 24 x 50 mm coverslip was placed over the slide and incubated 
for 1 minute 45 sec at 75oC on a heated PCR block.  The slides were dipped in ice-cold 2x SSC 
followed by a dehydration in ice-cold ethanol series (70%, 90%, and 100%) and air-dried.   
The probes were then denatured by heating at 75oC for 5 min and quickly cooling on ice.  They 
were placed on the marked area of the slides, an 18 x 18mm coverslip was placed over it and sealed 
using rubber cement and hybridized for 20-24h in a humidified chamber.  The signals were amplified 
and detected using anti-avidin and cy2-labelled streptavidin antibodies for the biotin labeled probe and 
anti-DIG and Alexa-594 antibodies for the DIG labeled probe. 
A red and a green signal (or a yellow overlap) on a single chromosome confirmed cis targeted 
clones. Such clones were used to generate mice with the floxed allele as well as the deleted keratin 
cluster allele. 
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3.2.5.4. Genotyping of ES cells or mice from tail tip DNA 
 
Metallic ear marks were used for labeling mice. After ear marking, 0.5 - 0.8 cm mouse tail 
biopsies or ES cells (1 x 25 cm2 flask) were subjected to lysis using 200 μl of lysis buffer containing 0.5 
μg/μl proteinase K and 0.5μg/μl RNase and incubated overnight at 55°C. After incubation, lysates were 
centrifuged at RT for 5 min at 20,000 x g. Supernatant was transferred to a new tube and 160 μl 
isopropanol was added and mixed well. DNA was fished out by using the yellow Gilson tip and washed 
by dipping in 500 μl 70% ethanol for 5 sec. After washing, the tip with DNA was placed into a new tube 
containing 200 μl TE buffer. The tubes were incubated for 10 min at 65°C to evaporate residual ethanol. 
The tubes with DNA were closed and further incubated at 55°C for 1 - 2h to facilitate complete DNA 
dissolution.  1 μl of this DNA was used for genotyping using appropriate primers listed in section 3.1.10.  
 
3.2.6. Dissection and processing of mouse embryos 
 
All mice were housed in a facility maintaining 12:12h light:dark cycle. For the generation of 
homozygous mutants of the keratin type II cluster, 6-18 week old heterozygous females were placed 
along with 8-48 week old males late in the evening.  The presence of a vaginal plug the following 
morning indicated that mating had taken place. The day on which the vaginal plug was observed was 
designated day 0.5 of gestation (E0.5). The pregnant females were sacrificed at various stages of 
gestation by cervical dislocation and the uteri were dissected out. Individual implantation sites were 
embedded in Tissue Tek OCT in a cryo mould, immediately frozen in pre-cooled isopentane and stored 
at -80oC for immunohistochemical studies. For histological analysis, the implantation sites were 
incubated in 4% paraformaldehyde overnight with constant rotation.  The implantation sites were 
washed 3 times 5 min in ice cold PBS and then incubated with constant rotation in 15% sucrose o/n 4oC  
followed by 30% sucrose ON at 4oC or until the tissue sunk to the bottom of the container.  The tissues 
were then processed for paraffin embedding.  For protein biochemistry and RNA isolation, the uterine 
muscle was carefully ripped off from the implantation sites.  The decidua was then carefully ripped apart 
to retrieve the embryo and the yolk sac.  A part of the yolk sac was retained for genotyping, and the 
embryo and the yolk sac were processed for protein isolation or total RNA isolation.   
 
3.2.7. Total RNA isolation 
 
Embryos along with their yolk sac (approx 10 mg) were collected as described above and 
immediately homogenized in 1 ml TRIzol reagent using a Polytron. The homogenized samples were 
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incubated for 5 min at 15 to 30°C to permit the complete dissociation of nucleoprotein complexes. 0.2ml 
of chloroform was added per 1 ml of TRIZOL reagent. Tubes were shaken vigorously by hand for 15 sec 
and incubated at 15 to 30°C for 2 to 3 minutes. The samples were centrifuged at no more than 12,000 x 
g for 15 min at 2 to 8°C. Following centrifugation, the aqueous phase was transferred to a fresh tube. 
0.5 ml of isopropanol was added (per 1 ml of TRIZOL reagent used for the initial homogenization). 
Samples were incubated at 15 to 30°C for 10 min and centrifuged at no more than 12,000 x g for 10 min 
at 2 to 80°C. After the supernatant was removed, the RNA pellet was washed once with 1 ml 75% 
ethanol pre-equilibrated at 4oC. The samples were mixed by vortexing and centrifuged at no more than 
7,500 x g for 5 min at 2 to 8°C. The supernatant was discarded and the RNA pellet was briefly air-dried 
for 5-10 min. RNA was dissolved in RNase-free water and incubated for 10 min at 55 to 60°C. RNA 
concentration was determined by UV spectrophotometer and the RNA quality was checked on a 0.8% 
agarose gel. Total RNA samples were stored at -80°C.  
 
3.2.8. RT-PCR for keratin mRNA expression in embryos 
 
For the reverse transcription reaction, 2 μg total RNA isolated from embryos was incubated with 
20 pmol of oligonucleotide primers at 70°C for 10 min. After a short cooling on ice, 1x first strand buffer, 
10mM dithiothreitol, 1 mM dNTP’s, 20 U of RNAsin (1U) were added to a total volume of 19 μl with 
RNase free water, mixed and incubated at 42oC for 2 min.  200 U of Superscript II reverse transcriptase  
was added to the reaction mix, mixed by pipetting up and down and incubated at 42°C for 50 min.  The 
reaction was stopped by incubating the reaction at 72oC for 15 min.   The reaction mix was taken 
directly for the PCR reaction.  PCR was performed in a 25 μl reaction mixture containing 1 μl of template 
cDNA, as detailed in section 3.2.4.5 for 20, 25 and 35 cycles.   
 
 
3.2.9. Histotechniques 
 
3.2.9.1. Cryosectioning and Immunofluoresence 
 
3.2.9.1.1. Cryosectioning 
 
Cryosectioning steps were carried out using a Leica CM3050 S Cryostat (Leica Microsystems, 
Bannockburn, IL). Implantation sites dissected from the mice were oriented in OCT in an appropriate 
sized cryo mould (Samura Finetek, Europe, NL) and dropped into pre-cooled isopentane (in dry ice), 
and then stored at -80°C until further processing. When the tissue was ready for cryosectioning, the 
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block was equilibrated at -21oC (in the cryostat chamber) for 1 to 2hs. OCT. compound was applied to 
the chuck and spread using the heat extractor. While about the freeze, the cryo block was placed on the 
chuck and pressed firmly. Excess OCT was trimmed and 12 μm thick sections were prepared.  The 
sections were collected on SuperFrost® plus microscope slides and allowed to dry for 3-4h.  The slides 
were then processed for immunohistochemistry or stored at -80oC until further use.   
 
3.2.9.1.2. Immunofluoresence staining of tissues  
 
Frozen sections (12 μm thick) were fixed for 10 min in –20°C acetone, and dried for 30 min 
before further processing. All antibodies were diluted in PBS containing 1% BSA. The primary antibody 
was applied with optimal dilution (listed in section 3.1.14.1) and incubated for 1h at room temperature. 
After washing 3 times in PBS for 5 min, appropriate secondary antibody at optimal dilution (listed in 
section 3.1.14.2.) was applied and incubated for 45 min. The nuclei were counterstained using 1:800 
diluted 4,6- Diamidino-2-phenylindole (DAPI) along with the secondary antibody. After washing 3 times 
in PBS for 5 min, slides were mounted with Prolong Gold (Invitrogen, Germany). Image analysis and 
processing were performed using the AxionVision 2.05 (Carl Zeiss) and Adobe Photoshop 6.0 software.  
 
3.2.9.2. Paraffin sectioning and haematoxylin & eosin staining  
Implantation sites were fixed and processed as detailed in section 3.2.6.  Once the tissues were 
embedded in paraffin blocks, they were cut into 5 μm thick sections using a microtome. The sections 
were the floated on a warm water bath (40oC) in order to remove wrinkles. They were then picked up on 
a glass microscopic slide and processed for H & E staining. The sections were de-waxed by immersing 
the slides in 3 changes of xylene for 5 min each followed by rehydration in a 100%, 96%, 70% alcohol 
series for 3 min each.  The slides were then immersed in water before they were stained with H & E.  
For staining, the slides were immersed in filtered Hematoxylin for 1 minute and washed with warm water 
until the water was clear.  The slides were then immersed in eosin for 30 sec and rinsed well with 
distilled water until the water was clear. The slides were then dehydrated in alcohol series – 2 times 
70% alcohol, 2 times 96% alcohol and 2 times 100% alcohol, 5 minutes each time.  Finally the slides 
were cleared with two changes of xylene and coverslips were mounted on to the glass slides using DPX 
mounting medium.  
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3.2.9.3. Immunohistochemistry (IHC) 
The paraffin sections were de-parafinized by incubating 3x for 10 min in xylene.  The sections 
were then re-hydrated by incubating 2 times, for 2 min each in alcohol series (100%, 95%, and 70%). 
The sections were then subjected to antigen retrieval by subjecting them to microwave treatment for a 
gradual increase up to 100oC, 10 min, followed by maintaining the temperature at 100oC for 10 min 
either in citrate buffer or EDTA buffer.  The sections were allowed to cool at bench top for 30 min 
followed by three washes for 5 min each in distilled water.  Endogenous peroxidase was quenched by 
incubating the slides for 10 min in either 1% or 3% hydrogen peroxide depending on the specification of 
the antibody.  After three washes with distilled water for 5 min each, the sections were blocked with 5% 
normal goat serum for 1 h at RT.  Primary antibody dilution was prepared in 5% normal goat serum 
diluted in TBS-T ON at 4oC. The sections were washed 3x 5 min, followed by linking and detection using 
Biotin/Streptavidin system (BioGenex) according to the manufacturers’ protocol.  
 
3.2.10. Protein biochemistry 
 
3.2.10.1. Preparation of protein lysates 
 
Protein lysates from total embryo or yolk sac at E9.5 were prepared by dropping them directly 
into boiling 5x sample Laemmli buffer containing 1x protease inhibitor and 1x phosphatase inhibitor in a 
volume of 50 μl. The samples were boiled for 15 min and centrifuged at 20,000 g for 2 min.  The 
supernatant was transferred into a fresh 1.5 ml Eppendorf tube and were shock frozen using methanol 
and dry ice.  The samples were stored at -20oC. 
 
 
3.2.10.2 SDS-PAGE  
 
Protein lysates were separated on a SDS-polyacrylamide gel prepared according to the 
compositions mentioned in table 3.1.   
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Table.3.1 Reagents for SDS-PAGE separating gel 
Total volume: 10 ml 
 
 
Table.3.2. Reagents for 5% SDS-PAGE stacking gel 
 
 
The protein samples were denatured at 98°C for 5 min, centrifuged briefly and allowed to cool 
to room temperature.  Depending on the molecular weight of the protein analysed, the samples were 
loaded onto SDS-PAGE of 8% or 10% or 125% gels, in an apparatus containing running buffer in both 
chambers. A constant voltage of 40 V was applied per gel until the loading dye (bromophenol blue) 
entered the separating gel. Then the voltage was increased to 80 V until the dye reached the bottom of 
the gel. The proteins were then blotted onto nitrocellulose membranes. 
 
3.2.10.3. Western Blotting 
 
PVDF membrane was activated in methanol for 1 min and then equilibrated for 10 min in 1x 
Towbin buffer. The SDS-polyacrylamide gel was dismantled from the electrophoresis equipment and the 
stacking gel was excised.  The separating gel was equilibrated in 1x Towbin buffer for 10 min and set up 
for semi-dry blotting as per manufacturers’ directions. Protein transfer was achieved at a constant 
current of 1.0 mA/cm2 of membrane. After blotting, the membrane was stained with Coomaasie G250 
Percentage of Gel 
Ingredients 
8% 9% 10% 12% 15% 
30% 
Acrylamide 
2.7 ml 3 ml 3.3 ml 4 ml 4.5 ml 
Lower Tris 2.5 ml 2.5 ml 2.5 ml 2.5 ml 2.5 ml 
Distilled water 4.8 ml 4.5 ml 4.2 ml 3.5 ml 3 ml 
Temed 10 µl 10 µl 10 µl 10 µl 10 µl 
10 % APS 100 µl 100 µl 100 µl 100 µl 100 µl 
Ingredients Volume for 4.5 ml 
30% Acrylamide 440 µl 
Upper Tris 1000 µl 
Distilled Water 2.6 ml 
Temed 6 µl 
10% APS 40 µl 
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stain and destained with destaining solution.  The marker was re-marked using a pencil and the 
membrane was scanned for future reference.   
For Western blotting, the membrane was washed with TBST buffer. Non specific binding sites 
were blocked by incubating the membrane with either 5% skimmed milk powder or 5% BSA in TBS 
containing 0.1% tween-20 (TBS-T) for 1h. After blocking, the membrane was incubated with primary 
antibody diluted in blocking solution for 1 hour at RT or o/n at 4°C and washed thrice with TBS-T for 5 
min each at RT, to remove any unbound antibodies. The membrane was then incubated with 
corresponding secondary antibody, diluted in blocking solution for 1 hour at RT and washed thrice with 
TBS-T for 5 min each at RT. A final wash was carried out with 1x TBS, pH 7.5. Bound antibodies were 
visualised with ECL system (Amersham Pharmacia) according to the manufacturers’ protocol or with 
indigenous ECL system. 
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4. RESULTS 
 
Generation and analysis of keratin type II null mice. An approach to overcome functional redundancy of 
keratin genes by a global deletion of type II keratins. 
 
4.1. Insertional targeting in ES cells  
 
4.1.1. Targeting constructs 
 
For the purpose of a large scale genomic deletion up to about 0.7 Mb, the scheme developed 
by Bradley and colleagues has been used. This is based on two consecutive homologous recombination 
events, one at each end of the target locus (Zheng et al., 1999). The targeting vectors used in this 
project have been isolated directly from genomic libraries of pre-made targeting vectors (Adams et al., 
2004). The libraries were generated from genomic DNA prepared from the livers of male 129S5 mice 
and they are indexed and displayed in the Ensembl website (www.ensembl.org).  These libraries were 
constructed with phage vectors with automatic plasmid excision capabilities. In the phage vector, a 
plasmid backbone (bacterial origin of replication and ampicillin resistance gene) and two tandemly 
arrayed loxP sites that flank all the elements except the phage arms, were included. Any phage clone 
from the library can be excised into a plasmid by Cre-induced loxP site recombination in a Cre-
expressing bacterial strain. The loxP site that is retained is used in the consecutive chromosome 
engineering steps. The genomic insert is flanked by rare AscI sites which can be used to change the 
orientation of the insert relative to the vector sequence in one sub-cloning step, if required (Zheng et al., 
1999). These indexed vectors constitute a public resource (Mutagenic Insertion and Chromosome 
Engineering Resource; MICER) for high-throughput targeted manipulation of the mouse genome 
(Adams et al., 2004).   
The construction and details of the 5’ hprt and 3’ hprt have been discussed in section 2.2.1. The 
5' hprt (MHPN) vectors sequenced at both ends are displayed as either black or red arrow bars 
depending on the orientation of the loxP site and indexed on the Ensembl webpage.  Similarly, the 3' 
hprt (MHPP) vectors, sequenced at both ends, are colored either blue or green depending on the 
orientation of the loxP site and are indexed on the Ensembl webpage (Fig.4.1a). The unique feature of 
these libraries is that, any clone that is isolated from the library is essentially ready to be used in 
targeting experiments. An added advantage in using clones from these libraries is that, they are 
indicated along with the expected orientation of the loxP site on targeting. Hence, selection of targeting 
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constructs, initially with identical orientation of loxP sites, eliminates the possibilities of undesirable 
inversion events in the initial stages of targeting (Adams et al., 2004).  
These insertion vectors integrate into the target locus, generating an allele characterized by an 
insertion of the entire vector sequence, flanked by a duplication of the region of homology (Hasty et al., 
1994) (Fig.4.1b). This feature makes this type of vector highly mutagenic. 
The MICER vectors carry the agouti (A) (Kucera et al., 1996) or tyrosinase (Tyr) (Yokoyama et 
al., 1990) coat-color markers. These are useful in tracking targeted alleles during breeding, in many 
cases eliminating the need for molecular genotyping. Both minigene cassettes are susceptible to 
position effects; different loci exhibit different degrees of pigmentation. The agouti minigene mediates a 
visible pigmentation change in all loci examined to date, but the tyrosinase minigene is silent in some 
loci (Klysik et al., 2004; Nishijima et al., 2003; Walz et al., 2003; Zheng et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.1. Indexed targeting vectors displayed on Ensembl, under the DAS source MICER (a) End-sequenced vectors were mapped to 
the C57BL/6J mouse genome assembly in Ensembl. 5' hprt (MHPN) vectors sequenced at both ends are colored black or red; 3' hprt 
(MHPP) vectors sequenced at both ends are colored blue or green. The orientation of the loxP site in these vectors is indicated by the 
direction of the arrow and by the color-coding. End-read sequences are shown in grey. (b) MICER vectors target by insertion. A', a', B' and 
b' correspond to genomic DNA from the vector and locus and illustrate the structure of the targeted allele. Exons 1−2 and exons 3−9 
correspond to the split hprt minigene elements in the 5' and 3' hprt vectors, respectively. After expression of Cre, these elements 
recombine, resulting in resistance to hypoxanthine/aminopterin/thymidine. Minigenes for the coat-color markers agouti (A) and tyrosinase 
(Tyr) are shown. The location and direction of promoter elements is indicated by an arrow. For the exon 3−9 cassette, which is 
promoterless, the direction of transcription is indicated (Adapted from Adams et al., 2004). 
   
The following two targeting constructs were procured from the Sanger Institute, Cambridge, UK.   
 
4.1.2. Targeting the 5’ end of keratin type II cluster 
 
A 5’ hprt vector construct, named MHPN117k13, was used for targeting the 5’ end of the type II 
keratin cluster.  This contained an insert of 6.0 Kb spanning 101202450 -101208417 bp on chromosome 
5’ HPRT (MHPN)
3’ HPRT (MHPP)
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15.  A gap of 1.5 Kb was generated using unique restriction sites, NheI and Bsp119I, to yield 2.0 and 
2.4 Kb arms of homology (Fig.4.2a).  NotI linkers were introduced at the cut sites in order to obtain a 
NotI restriction site. Hence, the plasmid was linearized using NotI before gene targeting.  The linearized 
and purified plasmid was transfected into AB2.2 cells and G418 selection was initiated after 24 hours 
following targeting, at a concentration of 350 μg/ml.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.2. Targeting of 5’ end of the keratin type II cluster by gap repair insertional targeting. (a) The 5’ targeting vector 
(MHPN117k13) consists of a neomycin resistance gene for gene targeting, a loxP site, a 5’-half-hprt (hypoxanthine phosphoribosyl 
transferase) minigene (non-functional hprt fragment) for chromosome engineering and a 4.5 kb genomic DNA fragment homologous to the 
5’ end of the type II keratin  cluster.  A gap of 1.5 Kb was generated by using NheI and Bsp119I enzymes. (b) Locus at 5’ end of keratin 
type II cluster. (c) During targeted recombination, the gap is repaired from the chromosomal DNA template which leads to a duplication of 
the entire region of homology including the repaired gap sequence, which will flank the inserted vector sequence. PCR primers for initial 
confirmation of homologous recombinants spanned the gap sequence and the proximal vector sequence. (d) Southern blot analysis of ES 
clones targeted at the 5’ end using the sequence from the ‘gap’ region as a probe which distinguishes Bsp119I fragments of 4.5 Kb in the 
WT and 8.9 Kb in targeted allele. 
 
WT PCR positive clones 1       2       3       4          5        6        7       8 
4.5 Kb 
8.9 Kb 
4.5 kb 8.9 kb
BsrGIBsrGIBsrGIBsrGI
Gap
region
Ty 5’HPRT GapregionNeo
BsrGI
BsrGIBsrGI 4.5kb
2.1 2.4 
Gap
region
Ty5’HPRTNeo
1.5
Gap
region
Targeting construct 
Targeting locus 
Targeted locus 
a
b
c
d
NheI Bsp1191 
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After about 7 days following selection, individual ES colonies visible to the naked eye were 
formed.  96 colonies were picked and screened using the primers listed in section 3.1.10 according to 
the conditions listed in section 3.2.4.1. The plasmid without the gap was used as a positive control.  
Eight PCR positive clones for the homologous recombination event were expanded and frozen until 
confirmed by Southern analysis. Southern analysis was carried out as outlined in section 3.2.5.2.  The 
probe was a 397 bp genomic DNA fragment that was designed in the gap region using the primers listed 
in section 3.1.10.  The probes distinguish between 4.5 Kb wild type and 8.9 Kb targeted Bsp14071 
(BsrGI) digested fragments in homologously recombined clones (Fig.4.2c-d). Five out of the eight PCR 
positive clones were positive for the homologous recombination at the 5’ end of the keratin type II 
cluster using Southern analysis.  Clone # 2 was used to target the 3’ end of the keratin type II cluster. 
 
4.1.3. Targeting the 3’ end of keratin type II cluster 
 
A 5’ hprt vector construct named MHPN322c09 was requested from Sanger Institute. The insert 
was excised from this vector at the AscI sites, which were present at either ends of the insert, and was 
cloned into an empty 3’ hprt vector and was named MHPP322c09. This contained an insert of 6.9 Kb 
spanning 101876016 – 101882964 on chromosome 15.  A gap of 1.4 Kb was generated using a double 
cutter, SacI, restriction sites to yield 3.0 and 2.4 Kb arms of homology (Fig.4.3a).  SacI restriction 
enzyme was used to linearize the plasmid and targeted into clone # 2 of the previously targeted clone 
detailed above (section 4.1.2).  Targeting in ES cells was performed as mentioned earlier. The cells 
were subjected to puromycin selection at the concentration of 3μg/ml for 24 hours following 
electroporation.  Eight clones out of 96 picked clones were positive for the homologous recombination 
event, as determined by PCR using the primers and conditions listed in section 3.1.10.  These clones 
were expanded and frozen until confirmed by Southern analysis.  
 Southern analysis was carried out as outlined in section 3.2.5.2.  The probe was a 487 bp 
genomic fragment that was designed within the gap region, using the primers listed in section 3.2.5.2.  
The probes distinguished between 7.0 Kb wild type and 12.9 Kb targeted HincII digested fragments in 
the correctly targeted clones (Fig.4.3c-d).  
All the PCR positive clones were positive for the homologous recombination at the 3’ end of the 
keratin type II cluster using Southern analysis.   The results for the targeting experiments are outlined in 
table 4.1. 
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Fig.4.3. Targeting of 3’ end of the keratin type II cluster by gap repair insertional targeting. (a)The 3’ targeting vector (MHPP322c09) 
contains a puromycin resistance gene, a loxP site, a 3’-half hprt minigene (non-functional hprt fragment) and a 6.3 kb genomic DNA 
fragment homologous to the 3’ end of the keratin cluster. A gap of 1.4 Kb was generated by using SacI restriction enzyme. (b) Locus at 3’ 
end of keratin type II cluster. (c) During targeted recombination, the gap is repaired from the chromosomal DNA template which leads to a 
duplication of the entire region of homology including the repaired gap sequence, which will flank the inserted vector sequence. PCR 
primers for initial confirmation of homologous recombinants spanned the gap sequence and the proximal vector sequence. (d) Southern 
blot analysis of ES clones targeted at the 3’ using the sequence from the ‘gap’ region as a probe which distinguishes HincII fragments of 
7.0 Kb in the WT and 12.9 Kb in targeted allele. 
 
 
 
 
 
 
 
 
Table.4.1. Targeting efficiency at the keratin type II locus using insertional vectors. The gap is excluded when calculating the total 
size of region of homology. An expected targeting efficiency of 8% was obtained with both the targeting constructs.  
WT PCR positive clones  1       2       3        4       5        6        7       8 
7.0 Kb 
12.9 Kb 
7.0 kb
12.9 kb
HincIIHincIIHincIIHincII
Gap
region
Ag3’HPRTPuro Gapregion
HincII
HincIIHincII
7.0 kb
3.0 2.4 
Gap
region
Ag 3’HPRT Puro
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4.2. Identification of cis targeted clones 
 
Double targeted ES clones in trans will give rise to a deletion and duplication product on Cre 
expression, while in cis will yield only a deletion product (Fig. 2.2 & 2.3). In order to identify if the double 
targeted ES clones were in cis or trans, fluorescent in-situ hybridization was employed and performed 
as detailed in section 3.2.5.3.  Slide preparation of metaphase chromosome spreads was carried out as 
suggested by Henegariu et al., 2001.  Empty 3’ hprt and 5’ hprt vectors were labeled with biotin-dUTP 
and digoxigenin-dUTP respectively, by nick translation and were used for chromosomal in-situ 
hybridization against spread chromosomes from double targeted ES cell clones (Wrehlke et al., 1999). 
The 5’ hprt probe was detected following signal amplification using anti-digoxigenin and Alexa-594 
antibodies. The 3’ hprt probe was amplified and detected using anti-avidin and cy2-labeled streptavidin.   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.4. Fluorescent in-situ hybridization to identify double targeted ES clones in cis. Empty 3’ hprt and 5’ hprt vectors were biotin 
and DIG labeled respectively, by nick translation and were used for chromosomal in situ hybridization against spread chromosomes from 
double targeted ES cells clones. A red and a green signal (or a yellow overlap) on a single chromosome confirms cis targeted clones 
(arrow).  
 
A red and a green signal (or a yellow overlap) on a single chromosome confirmed double 
targeting in cis (Fig.4.4). One of the three double targeted clones tested by FISH was confirmed to have 
the targeted constructs in cis. This clone was expanded and subjected to Cre expression. 
 
4.3. Cre-mediated deletion of the keratin type II cluster  
 
 
The double targeted clone in cis (Fig.4.5a), was expanded and transiently transfected with 200 
μg of circular CrePac vector (Taniguchi et al., 1998). This expression vector also expresses the 
puromycin N-acetyltransferase (pac) gene, which would have hindered the screening procedure if the 
resistance / sensitivity strategy in order to identify cis targeted clones (Fig.2.4) (Ramirez-Solis et al., 
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1995; Yu and Bradley, 2001) was adopted. However, since fluorescent in-situ hybridization was 
performed for this purpose, utilizing this vector, which was already available within the University, was 
efficient.  HAT selection was started 24 hours after transfection at a 1x concentration.  After about 7 
days following selection, individual ES colonies visible to the naked eye were formed.  During this time, 
a Cre-mediated recombination should have occurred, leading to the deletion of the keratin type II cluster 
along with the puromycin and neomycin selection cassettes as a reciprocal product, thereby uniting the 
two non-functional halves of the hprt cassette, rendering it functional (Fig.4.5b).  Such clones were HAT 
resistant and the transfection efficiency was about 80%.  Six HAT resistant colonies were picked and 
screened using the primers listed in section 3.1.10, according to the condition listed in section 3.2.4.4. 
The HAT resistant clones were further confirmed by Southern analysis for deletion of the keratin type II 
cluster (Fig.4.5c).  Sequences spanning the 5’ hprt (616 bp) and the 3’ hprt (656 bp) cassettes were 
used as Southern probes in order to distinguish between the double targeted and recombined loci 
(Fig.4.5c). 
All the HAT resistant clones after Cre expression were positive for the Cre-mediated deletion of 
the keratin type II cluster.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.5. Cre-mediated deletion of keratin type II cluster. (a) Double targeted keratin type II locus in cis.  Both the loxP sites are targeted 
in the same orientation. (b) Cre-mediated recombination between two loxP sites of double targeted clones in cis (on the same 
chromosome). This led to a deletion of the keratin cluster thereby rendering the clones neomycin and puromycin sensitive due to the loss 
of the neo- and puro-carrying reciprocal product, but HAT resistant. (c) Southern blot analysis of ES cells following Cre-mediated 
recombination was carried out using unique 5’ and 3’ probes spanning the 5’ hprt and the 3’ hprt, respectively. The 5’ hprt probe 
distinguishes between double targeted 8.3 Kb and a recombined 4.9 Kb HinDIII fragments using the 5’ hprt probe. Similarly, the 3’ hprt 
probe distinguishes between double targeted 14.3 Kb and recombined 10.5 Kb EcoRI fragments.  
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4.4. Blastocyst injection 
 
Clone # 1 was used for blastocyst injections which were carried out by Mrs. Rodica Maniu, 
University of Bonn, according to standard protocols. Six male chimeras were generated in total with 
about 80% contribution from the ES cells as determined by the contribution of ES cells to coat color.  
The chimeras were bred to C57BL/6 WT females.  All the chimeric males produced agouti colored 
offsprings indicating germline transmission.   
 
4.5. Generation of keratin type II null mouse line 
 
The agouti-colored male offsprings from breeding chimeras to WT C57BL/6 mice were 
genotyped.  Consistently, the agouti-colored offsprings carrying the deleted allele had a lighter tail color 
when compared to the WT, due to the presence of agouti coat color markers present in the targeting 
construct (Zheng et al., 1999) (Fig. 4.6). Mating heterozygous with wild-type mice, the mutant allele was 
detected in approximately 50% of progeny (data not shown). They were viable and fertile and exhibited 
no obvious phenotypic defects. The heterozygous males were backcrossed to WT C57BL/6 females in 
order to rapidly increase the colony. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.6.Tail color conferred by K14 agouti gene. Heterozygous mice for the deleted keratin type II cluster consistently had a lighter tail 
when compared to their wild-type littermates, allowing for rapid visual genotyping.  
 
Heterozygous males and females were in-bred to generate the keratin type II cluster knockout 
mice. 
WT
Targeted
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4.6. Analysis of keratin type II null mouse line 
 
The analysis of the mice was carried out at the morphological level by histology, DNA level by 
PCR for genotyping of mice and embryos, at RNA level by RT-PCR and in-situ hybridization and at 
protein level by immunoblotting and histochemistry of embryos and extra-embryonic tissues.   
 
4.6.1. Genotype analysis of progeny from keratin type II heterozygous intercrosses 
 
Heterozygous offsprings appeared normal and fertile.  However no homozygous mutants were 
recovered at birth (Table 4.2). Based on the observation that the K8 null mice, K18/K19 double deficient 
mice and K8/K19 (Baribault et al., 1993; Hesse et al., 2000; Tamai et al., 2000) die between E9.5 – 
E12.5, concepti at various stages during mid-gestation were analysed. Genotypic analysis of embryonic 
litters revealed that the keratin type II null mutants were recovered at the expected Mendelian ratios until 
9.5 days postcoitum (dpc), with most homozygous mutants dying in-utero between 9.5 and 10.5 dpc 
(Table 4.2).  
 
 
 
 
 
 
  
 
 
Table 4.2. Genotype analysis of progeny from keratin type II heterozygous intercrosses.  Genotyped embryos that were in the 
process of resorbing were scored as inviable.  Postnatal mice were scored at P0.   
 
Hence, the fact that these mutants could phenocopy the K18/K19 (Hesse et al., 2000) or the 
K8/K19 (Tamai et al., 2000) double deficient mutants which died at E9.5 and E10.0, respectively, was 
not excluded. 
 
4.6.2. Transcription of type I keratins is not coupled with that of type II keratins 
 
In order to analyse if the deletion of the type II cluster was complete and to determine if the 
deletion of the type II cluster had an effect on the type I cluster, the transcription status of the simple 
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epithelial keratins that are normally expressed during early embryogenesis, was determined by a semi-
quantitative RT-PCR analysis from E9.5 embryos. 
A complete absence of transcripts for K8 and K7 were seen in the mutants after 35 cycles. A 
weak signal of K18 transcript was seen in the knockouts.  This can be attributed to the presence of 
processed keratin pseudogenes from residual contaminating genomic DNA (Hesse et al., 2001; 
Tschentscher et al., 1997). This was further validated by in-situ hybridization using K18 specific 
riboprobes in collaboration with Dr. David Simmons, University of Calgary (Fig.4.8). A complete absence 
of K18 mRNA on placental sections through trophoblast cells in mutants confirmed that the weak signal 
of K18 seen using RT-PCR was a result of processed keratin pseudogenes from residual contaminating 
genomic DNA. Transcripts of keratin 19 were seen at normal levels in both WT and mutants. This 
indicates that the transcription of the type I keratins is independent from that of the type II keratins and 
that the regulation of the type II keratin expression does not occur at the transcriptional level.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.7. Semi-quantitative RT-PCR analyses of simple epithelial keratins in WT and type II keratin null embryos at E9.5.  
Transcripts of keratins whose genes are encoded in type II keratin cluster were absent in the keratin type II null embryos. A low signal of 
K18 in the mutants was from unprocessed pseudogenes. Transcripts of K19 were seen at normal levels in mutant embryos when 
compared to their WT littermates.  
 
 
 
 
 
 
 
 
Fig.4.8. RNA in-situ hybridization of K18 to WT and mutant placenta. No K18 RNA was detected in the mutant placenta (b) when 
compared to that of the WT (a), confirming that the faint K18 transcript obtained by RT-PCR was from processed pseudogenes from 
residual contaminating genomic DNA. 
a b +/+ -/- 
Results 
- 60 - 
 
4.6.3. Expression of simple epithelial keratins in extra-embryonic tissues 
 
Immunohistochemical analysis of simple epithelial keratins like K8, K18, K7, and K19 which are 
expressed during early embryogenesis was carried out on acetone fixed cryosections of E9.5 WT and 
mutant embryos, using a keratin specific antibody.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.9. Comparison of the placental regions of E9.5 WT (a, c, e and g) and mutant embryos (b, d, f and h) for the independent 
expression of K8, K18, K7 and K19.  Absence of any keratin filaments confirmed the complete loss of keratin filaments in the mutants (b, 
d, f and h).  This indicated a complete loss of all type I and type II intermediate filaments during early mouse embryogenesis.  Expression 
of K19 was completely lost in the absence of its type II partner in the mutants although K19 transcripts were detected by RT-PCR. S, 
spongiotrophoblast; D, decidua; E, embryo; G, trophoblast giant cell. Scale bar, 20 μm. 
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In the wild type embryo, these keratins are strongly expressed in the trophoblast giant cells, EC, 
parietal and visceral yolk sac, amnion, surface ectoderm and primitive gut (Lu et al., 2005). The data 
revealed a complete loss of keratin filaments in the embryo and placenta (Fig.4.9) of the mutants. No 
traces of the type I keratin K19 was seen in the mutants. In contrast to other keratin null mutants, where 
an imbalance of keratins led to the aggregation of residual keratins, no aggregates of K19 in the 
mutants were seen (rev. in Coulombe and Omary, 2002) (Fig.4.9h). It has been reported that type I 
keratins on forced expression in fibroblasts do not force the expression of its type II keratin partner, but 
however, the same is true vice-versa. These results suggest the possibility that type I keratin expression 
may be dependent on the accumulation of unpolymerized type II keratin (Giudice and Fuchs, 1987). 
Type II keratin expression has been shown to precede type I keratins (Lu et al., 2005).  Therefore, 
possibly in the absence of type II keratins, K19 is subjected to proteosome degradation, ensuring the 
disposal of the relatively insoluble cellular components. Given the data that keratin 8 plays a protective 
role against TNF-alpha and Fas mediated apoptosis (Caulin et al., 2000; Inada et al., 2001), and the 
absence of K19 protein left open the question of increased apoptosis in the keratin null mutants. 
However, the absence of all early simple epithelial keratins provided, for the very first time, a complete 
keratin null situation during early embryogenesis.   
 
4.6.4. Morphological analysis of keratin type II null embryos 
 
Gross morphology of the wild type and keratin type II null mutant littermates at 9.5 dpc showed 
that these mutants developed normally until 8.5 dpc as seen in-utero.  By 9.5 dpc, the mutant embryos 
were smaller than their WT or heterozygous littermates (20-60% smaller) (Fig.4.9). However, all 
hallmarks for an E9.5 embryo were seen in the mutants confirming that the embryos were not retarded 
developmentally in the absence of keratins. No viable keratin type II null embryos were recovered after 
E10.5 (Table 4.1). At 9.5 dpc, mutant embryos appeared to be paler than their WT littermates (Fig. 
4.10).   
 
 
 
 
 
 
 
Fig.4.10. Gross morphology of E9.5 WT and mutant littermates.  The mutants were smaller (20-60%) and paler than their WT 
littermates. Scale bar 100 μm. 
+/+ -/-a b
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In collaboration with Prof. Dr. Dieter Hartmann, University of Bonn, it was identified that at E9.5, 
the intact yolk sacs of the keratin type II null mutants were pale compared with those of their wild-type 
littermates and vessels were not readily discernible.  The yolk sacs of mutant embryos were more 
translucent and had fewer blood vessels than that of wild type embryos (Fig.4.11a vs. 4.11b). The large 
vitelline vessel and numerous smaller vessels were clearly seen in WT yolk sacs. In contrast, numerous 
small pools of blood cells were present in the mutants with no organized vessel formation (Fig.4.11b). 
Some areas of the yolk sac completely lacked blood vessels in the mutants (arrow).  Semi-thin sections 
through the yolk sac revealed some areas totally devoid of blood vessels in the mutants (Fig.4.11c) 
when compared to that of the WT (Fig.4.11d), 
 
 
 *  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.11. Morphology of yolk sac in WT and keratin type II null mutants at E9.5. (a&b) Whole-mount photographs of WT and mutant embryos within its 
yolk sac at E 9.5, respectively.  Reduced vasculature is seen in the mutants when compared to their WT littermates.  Some regions within the yolk sac were 
completely devoid of vasculature [arrow]. The large vitelline vessel [VV] is clearly visible in the WT, whereas in the mutant, a disorganized vessel formation 
was seen.  Scale bar, 100 μm. (c&d) Semi-thin sections through the yolk sac of WT and mutant embryos, respectively. The sections from the WT yolk sac 
revealed main branches and secondary branches of vasculature. However, the mutants showed discontinuous vasculature and under-developed secondary 
branches. VV, Vitelline vessel. Scale bar, 100 μm.  
VV 
VV 
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Histological analysis of E9.5 yolk sacs revealed a clear difference in morphology between WT 
and mutant tissue. Individual vessels were clearly visible in WT tissue, with numerous regularly spaced 
attachments between the visceral endoderm and mesoderm layers (Fig.4.12a & b). However, the 
visceral endoderm and mesoderm were more widely separated in the keratin type II null tissue, with 
occasional attachments forming numerous large spaces that were sparsely populated with blood cells 
(Fig.4.12c & d). These histological findings clearly indicate a defect in either angiogenesis or 
vasculogenesis or both. In the mouse embryo, primitive erythroid cells begin to develop in yolk sac 
blood islands between embryonic days 7 and 8 (Haar and Ackerman, 1971; Silver and Palis, 1997).  
These blood islands are surrounded by a layer of endothelial cells. Low levels of  expression of K8, K18 
and K19 that are organized in file filaments have been reported to be expressed in the walls of some 
blood vessels in the umbilical cord of humans (Jahn et al., 1987). Therefore, whether this defect in 
angiogenesis is a primary or a secondary effect due to the lack of keratins requires further 
experimentation. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.12. Sections of the visceral yolk sac in WT and mutants. (a & b) Individual vessels are clearly visible in WT tissue (a) by the presence of 
embryonic blood [EB] and arrow heads, whereas the visceral endoderm [VE] and mesoderm [M] layers are more widely separated in the mutants (b). Scale 
bar, 10μm. (e&f) Sections of visceral yolk sac from WT and mutants, respectively, at higher magnifications. Regular attachments between visceral 
endoderm and mesoderm layers are depicted by asterisk in the wild type. Such attachments were rare in the mutants indicating a lack of regular vascular 
structures carrying lesser amount of fetal blood. Scale bar, 10μm. M, mesoderm; VE,visceral endoderm; EB, embryonic blood; Mb, maternal blood; Am, 
amniotic membrane; R, Reichert's membrane; PE, parietal endoderm; E ,embryo. 
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4.6.5. The keratin type II null embryos are distinct from other keratin null embryos reported till 
date 
 
Given the emerging data of the role of keratins in regulating protein synthesis (Kim et al., 2006), 
cell cycle (Margolis et al., 2006) and protection against apoptosis (Oshima, 2002), the keratin type II null 
mutants in all these settings were characterized.  Embryos in-utero seemed to develop normally until 
E8.5 as judged by eye. By E9.5, they were visibly smaller. To determine the basis for the embryonic 
lethality of keratin type II null mutants, morphology and histology of extraembryonic tissues at 8.5 -10.5 
dpc were examined. The mutant embryos were often developmentally retarded and smaller than their 
wild-type littermates by 9.5 dpc (Fig.4.10) and the consistent overt defect that might result in embryonic 
lethality at this stage was attributed to gross abnormalities in primitive hematopoiesis. The placentas of 
the mutant embryos developed normally until E8.5.  Attachment of the allantois to the chorionic plate 
and formation of a basement membrane between them were normal in mutant conceptuses by light 
microscopy (Fig.4.13b).  
However, there seemed to be a larger number of chorion trophoblast cells in the mutants and 
the chorionic plate [C] appeared flatter and more compact (Fig.4.13b) when compared to the WT 
(arrowheads, Fig.4.13a). Morphogenesis of the chorioallantoic interface and intrusion of underlying fetal 
blood vessels was apparent by E9.5 in wild-type (Fig.4.13c), but the chorionic plate in mutant mice 
remained flat and failed to interdigitate with the underlying allantoic mesoderm and blood vessels 
(Fig.4.13c & d).  Blood cells in the mutants were sparse (arrowheads, Fig.4.13d) when compared to the 
WT. This accounted for the paler mutant embryos in comparison with the WT (Fig.4.10). Maternal blood 
sinuses (asterix) were seen in normal numbers in both WT and mutant deciduas.  No mechanical 
fragility of any cell type was observed in contrast to those seen in the K18/19 (Hesse et al., 2000) and 
K8/19 (Tamai et al., 2000) double deficient embryos. Moreover, the lack of the labyrinth layer in contrast 
to the double deficient embryos clearly indicate that the phenotype seen in the keratin type II null 
embryos is distinct from that reported earlier (Hesse et al., 2000; Tamai et al., 2000).  
This is an indication that the phenotype described earlier by the two groups is not a 
consequence of the loss of keratins; instead, it could be attributed to ‘a gain of toxic function’ due to the 
presence of keratin aggregates. By E10.5, no live keratin type II null embryos were recovered 
(Fig.4.13f). These extraembryonic defects together with defective vasculogenesis and angiogeneisis, 
presumably compromised fetal-maternal circulation and hence efficient exchange of nutrients and 
oxygen between the embryo and maternal environment, causing the mutant embryos to die around E 
9.5.  
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 Fig 4.13. Comparison of histological sections through the implantation site of wild-type (a,c,e) mutants (b, d, f ). (a) In E8.5 WT embryos, the polar 
extraembryonic ectoderm generates the ectoplacental cone [EC] and the chorionic (ectoplacental) plate [C]. The ectoplacental cone penetrates into the 
uterine epithelium [U]. It contains embryo-derived diploid and polyploid (giant) trophoblast cells [G], as well as maternal blood sinuses [*]. The chorionic plate 
forms a solid wall of epithelial cells continuous with the ectoplacental cone and is fused to the mesoderm of the allantois [A], which contains extraembryonic 
blood vessels (arrowheads). (b) The E8.5 mutant embryos, contained larger number of embryo-derived diploid and polyploid (giant) trophoblast cells [G], 
and lesser number of ectoplacental cone precursor cells. (c) At E9.5, the WT placenta was made up of four regions: (i) the chorionic plate which is traversed 
by allantoic capillaries (arrowheads); (ii) the labyrinthine zone [L], which is composed of strands of diploid trophoblast cells and of a network of 
extraembryonic capillaries interspersed with maternal blood sinuses; (iii) the spongiotrophoblast zone [S], in which only maternal blood circulates; and (iv) 
the giant cell zone [G]. (d) At E9.5 in the mutants, the placenta contained only two regions.  The chorionic mesothelium failed to fold to form the labyrinth 
layer and the embryo derived spongiotrophoblast layer was also absent. Maternal blood sinuses were still seen [*] although the number of fetal blood cells 
were drastically reduced [arrowheads] (e) At E10.5, the labyrinthine zone in WT enlarges markedly. (f) At E10.5, the mutant embryos were completely 
resorped, leaving behind a blood filled cavity [H]. A, allantois; C, chorionic plate; D, diploid trophoblast; E, ectoplacental cone; E, embryo; G, giant cell zone; 
L, labyrinthine zone; S, spongiotrophoblast zone; U, uterine epithelium; arrowheads and asterix point to allantoic capillaries (containing nucleated 
erythrocytes) and to maternal blood sinuses, respectively. Scale bar, 100μm. 
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4.6.6. Keratins are not required for cellular proliferation during early embryogenesis 
 
The fact that keratins are not required for the early embryonic development has been reported 
by a phenotype rescue in K8 null (Kupriyanov and Baribault, 1998) and K18/K19 double deficient 
embryos by tetraploid aggregation (Hesse et al., 2005). However, emerging data from mouse genetics 
and human diseases has led to the hypothesis that changes in the expression of certain keratins have a 
profound impact on cell size, cell proliferation and the response to stress (Gu and Coulombe, 2007; 
Pallari and Eriksson, 2006).  Therefore, in order to analyse whether the mutant embryos are smaller 
than their wild type littermates due to a proliferation defect besides a nutritional deficiency was 
attempted. Cell proliferation was measured by immunohistochemistry with anti-phospho-histone H3 
(Ser10) antibody on PFA fixed, paraffin embedded transverse sections of E9.5 embryos in utero 
(Fig.4.14a-d). Labeled nuclei per 1000 cells were counted in each of the various cell types like the 
trophoblast giant cells, embryo, labyrinth, allantois and yolk sac from three independent experiments. 
Mitotic index was calculated as the percentage of total cells with histone H3 labeled nuclei (Fig.4.14e). 
No specific staining was observed in the absence of the primary antibody (data not shown). No 
significant changes in proliferating cells were observed in the mutant embryos in contrast to WT 
embryos even around the time of death of the mutants, indicating a lack of proliferation defect. 
In order to verify if the embryos were smaller due to a reduction in protein translation in the 
absence of a keratin protein as reported earlier (Kim et al., 2006), the surface area of cells from the 
extra-embryonic tissue, the trophoblast giant cells (TGC) was measured at random from three 
independent sections of WT and mutants (Fig.4.14f) using AxioVision LE software. The cell size varied 
considerably depending on the location of the trophoblast giant cell.  However, averaging over 100 cells 
counted in total, a slight increase of about 8% was observed in the cell size of the mutant TGC’s when 
compared to the WT.  However, at this point, it is still uncertain if there is an alteration in protein 
synthesis which leads to this change, or it is a structural consequence due to the absence of a keratin 
cytoskeleton. This can be assessed by metabolic labeling using [35S] methionine followed by calculating 
incorporation of radioactivity. An alternative approach has been initiated to analyse changes in protein 
synthesis by monitoring upstream regulators like Akt and downstream targets like S6 kinase in the 
mTOR pathway.  This will reveal if the changes in cell size of the trophoblast giant cells in the mutants is 
a consequence of loss of keratins on protein translation.  
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Fig.4.14. Immunohistochemical detection of phopspho-histone H3 in WT and mutant mouse placenta at day E9.5. (a & b) 
Abundant proliferating cells are seen in all cell types within the developing embryo in WT and in the mutant, respectively. Scale bar, 100 
μm. (c & d) Higher magnification images thorough the placenta of WT and mutant indicating labeled and unlabeled nuclei (arrows), 
respectively. ; Scale bar, 20 μm. (e) Mitotic index was calculated as the percentage of total cells with histone H3 labeled nuclei from three 
independent experiments. No value for labeled nuclei in the mutant labyrinth was scored due to the absence of this layer in the mutant. (f) 
Cell surface area measurements performed on trophoblast giant cells of WT and mutants. An increase of 8% in cell surface area was seen 
in the mutants when compared to the WT.  D, decidua; L, labyrinth; S, spongiotrophoblast, G, trophoblast giant cell; E, embryo.  
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4.6.7. Increased rate of apoptosis in mutants is likely a consequence of nutritional deficiency 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 4.15. Immunohistochemical detection of cleaved caspase-3 in WT and mutant embryos. (a&b) Active caspase-3 staining 
displayed as a cytoplasmic and/or nuclear pattern in cells undergoing apoptosis in wild type and mutant, respectively.  Positive cells for 
apoptosis had a condensed nucleus, a shrunken cytoplasm, and membranes blebbing consistent with morphological features of apoptosis 
(arrowheads). E, embryo; ys, yolk sac; am, amniotic membrane. Scale bar, 100μm (c&d) Higher magnification of embryo showing 
positively stained apoptotic cells in WT and mutant, respectively. Insets in c and d show control slides which did not receive any primary 
antibody from WT and mutant sections, respectively.  Scale bar, 20 μm. (e) The number of apoptotic cells in WT and mutant embryo 
sections were counted and expressed as a percentage of the total number of cells in the sections.  
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The type I keratin K18, which was deleted along with all the type II keratins in this work, has 
been reported to bind TRADD (Caulin et al., 2000). TRADD is an adaptor protein that is recruited to the 
liganded TNF receptor 1 and essential for downstream signal relay, including the formation of death-
inducing signaling complexes. Sequestration of TRADD’s interaction with K18 prevents it from being 
recruited to activated TNFR1, resulting in signal attenuation (Inada et al., 2001). Moreover, enhanced 
susceptibility to TNFα  following abrogation of the keratin–TRADD interaction was reported in K8 null 
embryos which die at mid-gestation due to a trophectoderm failure (Jaquemar et al., 2003).  
Hence, in order to exclude embryonic lethality as a consequence of apoptosis, susceptibility of 
keratin null embryos to apoptosis was determined by immunohistochemistry with cleaved caspase-3 
(Asp175) on PFA fixed, paraffin embedded sections of WT and mutant embryos at E9.5. The number of 
apoptotic cells in a 5μm sectioned embryo were counted and scored as a percentage from four 
independent experiments. About 3.8% of cells on an average in the WT were undergoing apoptosis.  
However, the variability in the percentage of apoptotic cells was very high in the knockouts, ranging 
from 3.5 % to 13.6%. A positive correlation existed the size of the embryo to the susceptibility to 
apoptosis. Smaller the embryos, larger were the number of apoptotic cells and vice-versa. This could be 
accounted to the fact that the embryos that were smaller were the ones with more severe vascular and 
labyrinth defects, hence with greater nutritional deficiency and a higher susceptibility to apoptosis 
(Fig.4.15). Moreover, the cells undergoing apoptosis were not restricted to epithelial cells, suggesting 
that apoptosis in these embryos was not a consequence of lack of keratins, but a secondary effect due 
to the lack of nutrition.  Therefore, it can be concluded that this 3-fold increase in apoptosis seen in the 
mutants is a consequence of nutritional deficiency.   
 
4.6.8. Altered cell-signaling in the absence of type II keratins 
 
 Given that the keratin type II null mutants die primarily due to nutritional deficiency, 
accompanied by an increase in apoptosis, it was hypothesized that this would be accompanied by an 
activation of pro-apoptotic p38 MAP kinase (Davis, 2000). It has been previously shown that p38α 
mitogen-activated protein kinase (MAPK) is essential for placental, embryonic and yolk sac 
angiogenesis. P38α mutants die at mid gestation with defects in the placenta, corresponding to a 
severe reduction in the spongiotrophoblast layer, as well as a near absence of the labyrinth layer due to 
a failure of vascularization by endothelial cells from the underlying chorionic plate.  The authors predict 
that p38α is required for the vascular remodeling associated with angiogenesis (Mudgett et al., 2000). 
The defects seen in the keratin type II null mutants have a striking similarity to those of the p38α null 
mutants.   
Results 
- 70 - 
Protein lysates from a pool of embryo and yolk sac at E9.5 from WT and mutants were 
subjected to immunoblotting against p38 and activated p38.  However, contrary to expectations, a 
reduction in the activated p38 levels up to 60% was observed from three independent experiments 
(Fig.4.16).   
 
 
 
 
 
 
 
 
 
 
 
Fig.4.16. Immunoblot analysis of p38 and activated p38 in WT and mutant embryos at E9.5.  The relative expression of p-p38/total p38 was assessed 
by densitometry from three independent experiments. A reduction of activated p38 levels were observed upto 60% in the mutants when compared to that of 
the controls. The bar graphs illustrate the mean percentage of  p38-p.  
 
 Moreover, recent data has suggested that K8 when phosphorylated at S73 by p38 MAP kinase, 
determines keratin organization (Woll et al., 2007).  Given this recent finding, it can be speculated that 
keratins play a role upstream in the p38 MAP kinase pathway in placental angiogenesis.  Future work 
will clarify alterations in upstream and downstream players in this pathway.  
 
4.6.9. Analysis of placental differentiation in the absence of keratins 
 
The absence of the labyrinth and the spongiotrophoblast layer, as determined by histological 
analysis would indicate an alteration in the differentiation of the placental lineage in the absence of 
keratin filaments.  Hence, in order to validate this hypothesis, in-situ hybridization on implantation sites 
of E8.5 and E9.5 embryos was carried out using several lineage markers in collaboration with Dr. David 
Simmons, University of Calgary, Calgary (Fig.4.17). The most significant change between the WT and 
mutants was seen in the expression of Syncytin A (SynA). SynA is a transmembrane protein, involved in 
the formation of the placenta syncytiotrophoblast layer generated by trophoblast cell fusion at the 
materno–fetal interface (Dupressoir et al., 2005). SynA is expressed in the layer of chorion cells that 
meet the EPC (chorion trophoblast cells) (Mi et al., 2000).  These cells are located opposite to Gcm1 
expressing cells and are predicted to form the second layer of the syncytiotrophoblast cells (D. 
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Simmons et al., unpublished data).  These cells also contribute to labyrinth formation at later stages. 
SynA expression was seen in the mutants at E9.5. However, the SynA expressing cells appeared flat 
when compared to the WT cells (Fig.4.17g & h)  and appeared to have a proliferation defect to elongate 
and inter-digitate.  This was consistent with the histological findings of an almost invisible labyrinth layer 
(Fig.4.13d).   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.4.17. In-situ hybridization analysis for lineage markers Pl1, Tbpba1, Gcm1 and SynA mRNA expression in E9.5 placentas. 
Differentiation of the placenta is appropriate in the mutants (b, d, f and h) as compared to the wild type placenta (a, c, e and g) EC, 
ectoplacental cone; C, chorion. 
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Expression of Gcm1 begins at E8.5 following chorio-allanotic attachment at the leading edge of 
where the chorion meets the allantois in WT embryos. Sites of Gcm1 expression become the initial 
branch points where fetal vessels grow into the chorion and start branching (Anson-Cartwright et al., 
2000; Cross et al., 2006). These branching points were established in the mutants indicating that the 
decreased vascularization seen in the placenta of the mutant cannot be attributed to a failure of the 
Gcm1 positive cells to interdigitate to form the labyrinth (Fig.4.17e&f).  In-situ hybridization with a probe 
for placental lactogen-1 (Pl-1), which  is a marker of all TGC’s which line the implantation chamber 
including those that arise from the outer layer of trophectoderm from the blastocyst (called primary 
TGCs) (Guillemot et al., 1994), detected an expansion of the giant cell layer in mutant placentas. The 
layer was, however, slightly disorganized (Fig.4.17b vs. 4.16a), but the expression level indicated a 
normal differentiation pattern of the trophoblast giant cells. The fourth marker, Tpbpa, is normally 
expressed in the ectoplacental cone at E8.5 in precursor cells of the spongiotrophoblast layer and later 
on in the spongiotrophoblast cells when they begin to form from E9.5 (Lescisin et al., 1988). Normal 
expression pattern of Tpbpa was observed in the ectoplacental cone of mutants as well as the WT at 
E9.5, indicating that spongiotrophoblast precursor cells are present in cells committed to generate the 
spongiotrophoblast layer. This would indicate a normal differentiation programme. Expression of the 
marker for trophoblast stem cells, Esrrb, which is normally switched off by E8.5 (Luo et al., 1997), was 
appropriately switched off in the keratin null mutants (data not shown). This indicated that the failure of 
the labyrinth formation as seen by H & E stained histological sections, cannot be attributed to a failure of 
the stem cells to differentiate into the proper precursors for labyrinth formation.  Expression of Prlpa that 
is expressed only in the secondary TGCs (Muller et al., 1998), originating from the EPC and the polar 
trophectoderm was normal in the mutants (data not shown), indicating that the mutants were able to 
generate additional TGCs following implantation.  
In summary, the in-situ hybridization data of various placental lineage markers at E9.5 clearly 
indicate that keratins do not affect cellular differentiation per se. The lethality of the mutant embryos at 
E9.5 cannot be attributed to a differentiation defect, but, to a proliferation defect of the SynA expressing 
chorionic trophoblast cells. It can therefore be concluded that the keratin type II null mice die due to two 
structural and functional defects. Firstly, altered angiogenesis and vasculogenesis in the yolk sac which 
manifests around E7.0 - E8.0 and secondly, due to a reduced feto-maternal interface with a dramatic 
reduction in the size of the labyrinth.   
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5. DISCUSSION 
 
5.1. Functional role of keratin multigene families 
  
Multigene families consist of a group of gene orthologs that have similar structures and distinct 
functions. The intermediate filament [IF] protein family is one such family (Fuchs and Weber, 1994). 
Vertebrate IFs are organised into five distinct gene families according to sequence identity and 
expression patterns (Fuchs and Weber, 1994; Herrmann et al., 2003), among which are the type I and 
type II keratin gene families.  However, unlike many other multigene families such as myosins (S and 
Saitou, 1999), connexins (Cruciani and Mikalsen, 2006), whose individual members are spread across 
the genome, gene families like those of keratins (Hesse et al., 2001), Hox (McGinnis et al., 1984) or the 
MHCs (1999), are clustered. Such gene families have been subjected to evolutionary constraints to 
maintain this arrangement, thereby representing a functionally significant group (He and Goldwasser, 
2005). The evolution of the keratin gene families have been studied for about three decades. Based on 
‘Phylogeny Analysis Using Parsimony (PAUP)’ set of programs, evolutionary trees were derived from 
the keratin protein sequences. The two keratin families showed extraordinary parallelism in their 
patterns of gene duplications. In both families, the genes expressed in embryos diverged first. This was 
followed by immense gene duplications, which eventually created the subfamilies expressed in various 
differentiated cells, like hair keratin genes, basal cell-specific keratin genes and keratins expressed in 
hyperproliferative conditions. The parallelism of gene duplications in the two keratin gene families 
reflects a mechanism in which duplications in one family influence duplication events in the other family 
(Blumenberg, 1988).  
The type I and type II keratins form obligatory heteropolymers by forming stable double-
stranded coiled-coil heterodimers, therby forming keratin filaments. The organization of keratin filaments 
varies with cell types.  In most epithelial cells, the keratin filaments spans the entire cytoplasm, from the 
surface of the nucleus to the cell periphery where it interacts with cell matrix (hemidesmosomes) and 
cell-cell (desmosomes) adhesion complexes (Gallicano et al., 1998; Guo et al., 1995). However, they 
form thick bundles in epidermal keratinocytes, they are apically restricted as densely woven mats in 
enterocytes, and they form subplasmalemmal enrichments in hepatocytes. The regulation of the 
organization of the keratin filaments within the cells is regulated by differential association of keratin 
filaments with scaffolding proteins and keratin modifications (Coulombe and Omary, 2002; Coulombe 
and Wong, 2004) such as the desmosomal plaque proteins desmoplakin/plakophilin/plakoglobin 
(Hatzfeld and Nachtsheim, 1996; Hofmann et al., 2000; Kowalczyk et al., 1999) and the 
hemidesmosomal components plectin and bullous pemphigoid antigen1 (Fontao et al., 2003; Steinbock 
et al., 2000). Plectin, which is a multifunctional cytoskeletal cross-linker may also participate in 
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attachment to other cytoskeletal elements and the nucleus (Leung et al., 2002; Rezniczek et al., 2004).  
Moreover, post translational modification like phosphorylation also is suggested to play a vital role in 
regulating keratin organization  since altered phosphorylation is often accompanied by structural 
changes (discussed below) (Omary et al., 2006). 
Until today, the progress made in defining the roles of keratins in vivo has originated mostly 
from studies involving genetically manipulated mice and disease conditions in humans. However, 
considerable uncertainty has evolved in interpretation of their phenotypes. Gene knockouts and 
mutational studies of 13 keratins analysed so far in mice have demonstrated phenotypes ranging from 
major defects causing embryonic lethality or skin fragility to subtle and late onset liver alterations (rev. 
Magin et al., 2004; rev. Kim and Coulombe, 2007). Several keratin-associated diseases in humans and  
phenotypes in mice are accompanied by the presence of intracellular aggregates of unpolymerized 
keratin proteins, that prove toxic to the cell (Omary et al., 2004; Watson et al., 2007; Zatloukal et al., 
2004), thereby exhibiting a dominant-negative effect. Moreover, characterizing individual keratin function 
by loss-of-function studies has been very challenging due to compensatory effects of an alternative 
keratin (Table 1.1). Significant redundancy among the multiple keratins can be related to a common 
ancestry (Blumenberg, 1988), clustered organization (Hesse et al., 2001; Hesse et al., 2004) and 
sequence relatedness of specific keratin genes (Hoffmann et al., 1985).   
Recent data have indicated roles for keratin intermediate filaments beyond structural support. 
The idea of keratins as “signaling platforms” as well as their structural functions may not be completely 
separable (Coulombe and Wong, 2004; Pallari and Eriksson, 2006; Paramio and Jorcano, 2002). In 
several epithelia, like in the basal epidermis, the keratin cytoskeleton protects cells against mechanical 
stress through formation of a three-dimensional cytoskeleton that associates with proteins of 
hemidesmosomes and desmosomes (Fuchs and Cleveland, 1998; Garrod et al., 2002; Green and 
Jones, 1996). While these interactions at the cell periphery are well documented and essential for 
epidermal integrity, associations of keratins with the nuclear envelope is not well understood, but are 
non-essential for nuclear positioning (Litjens et al., 2006; Magin et al., 1998; Venetianer et al., 1983). 
Reorganization of keratin IFs in response to extra- or intracellular signals predominantly involves 
phosphorylation at several Ser residues, leading to generation of granules and an increase of the 
soluble subunit pool. At the same time, Ser phosphorylation creates binding sites for 14-3-3 family 
adapter proteins, as demonstrated for K18 (Ku et al., 1998). Most recent findings have indicated a 
phosphorylation-dependent recruitment of 14-3-3 to K17, thereby regulating protein biosynthesis via 
mTOR signaling, and also the interaction of 14-3-3 with K8, K18 and K19 being a prerequisite for cell 
cycle progression (Kim et al., 2006; Margolis et al., 2006). Studies with keratin transgenic mice 
mimicking the mutations associated with cirrhosis and fibrosis progression, K8-G61C, revealed an 
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increased susceptibility to stress-induced liver injury and apoptosis. This was attributed to the inhibition 
of phosphorylation of K8 at S73 by stress-activated protein kinases such as p38, JNK and p42 (Ku and 
Omary, 2006). Similar susceptibility to stress was also observed in the S73A mutant wherein the site for 
phosphorylation was destroyed. A “phosphate sponge” hypothesis was formulated suggesting that 
keratins, during stress, would absorb the stress-activated phosphate kinases, thereby reducing their 
untoward effects, thereby protecting the cells from injury (Ku and Omary, 2006). Furthermore, in an 
injury model of lung alveolar epithelial cells, the keratin cytoskeleton disassembles partially in the 
presence of shear stress coincident with PKCδ-mediated phosphorylation of K8 at S73, indicating 
alterations in keratin organization in response to mechanical stimuli (Ridge et al., 2005).  Therefore, 
most properties reported for keratins are controlled by highly complex patterns of phosphorylation and 
molecular associations that have been carried out in vitro, which may not be a true representation of the 
situation in vivo.  
The work reported here is a novel in vivo approach, utilizing the clustering of the keratin gene 
family since it is well suited for functional studies by subjecting them to a large scale genome deletion. 
 
5.2. An in vitro chromosome engineering approach to study function of keratin in vivo 
 
A very challenging approach to overcome the problem of keratin function redundancy and 
significance of its evolutionary diversity was undertaken.  This thesis utilized the fact that all type II 
keratin genes are clustered in chromosome 15 in mice without any other known genes within the cluster 
(Hesse et al., 2001).The evidence that type II keratins are expressed prior to the type I keratins during 
early embryogenesis (Lu et al., 2005), and the presence of a type II keratin being required for the 
expression of the type I keratin (Giudice and Fuchs, 1987), offered an opportunity to generate a 
complete keratin null situation during early embryogenesis by a large scale genome deletion. Hence, it 
was possible to carry out a true loss-of-function analysis of type II keratins. 
Homologous recombination in ES cells using replacement vectors has generated deletion of 
genomic fragments up to 30 kb (Gu et al., 1993; Zhang et al., 1994). However, inducing large defined 
chromosomal rearrangements was only achieved in the mid-1990’s by taking advantages of the Cre-
loxP recombinase system (Herault et al., 1998; Ramirez-Solis et al., 1995; Smith et al., 1995; Van 
Deursen et al., 1995) and defining the chromosomal engineering strategy. This system worked very 
efficiently in deleting 0.68 Mb of the genomic locus spanning all type II keratins as well as the type I 
keratin Krt18 gene. The ES cells heterozygous for the deleted loci grew normally and were not lethal, 
indicating any consequence of the loss of a single highly dosage-sensitive gene cluster (Zheng et al., 
2000).  To the best of current knowledge, this is the first time a deletion of such a large gene family has 
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been carried out in mammals. Over the last 10 years, Duboule and collaborators have used this 
technique to analyze the molecular mechanisms that modulate expression of Hox genes encoding 
transcription factors controlling positional information along the trunk and limb axes (Herault et al., 1998; 
Kmita et al., 2002; Kmita et al., 2000; Kondo and Duboule, 1999; Kondo et al., 1998; Spitz et al., 2001; 
Zakany and Duboule, 1996). They have deleted up to 13 genes spanning up to 100 Kb of the genomic 
locus in Drosophila and remains the largest gene family reported to be deleted till date. However, the 
discovery of micro RNA (miRNA) genes within the Hox gene cluster, that regulate the expression of the 
Hox genes, has added a new dimension to the complexity to the regulation of these Hox genes (Chopra 
and Mishra, 2006; Tanzer and Stadler, 2004). There are at least three groups of miRNA’s residing within 
the Hox gene cluster. However, no miRNA genes reside within the keratin clusters in mouse and human 
as per miRBASE sequence database, Release 10.0 August 2007 
(http://microrna.sanger.ac.uk/sequences/index.shtml). In summary, it can be stated that the strategy 
undertaken in this work to create a large scale genome deletion was efficient, and that the interpretation 
of data is most likely not obscured by affecting miRNA’s. 
 
5.3. Growth retardation and lethality of keratin type II null embryos is a consequence of defects 
in the yolk sac followed by placental defects 
It has been reported that K8 and K18 form the first IF in embryogenesis in the trophectoderm, 
complemented by K19 (Brulet et al., 1985; Jackson et al., 1980; Lu et al., 2005). Gene ablations from 
various IF genes like desmin (Li et al., 1996; Milner et al., 1996), vimentin (Colucci-Guyon et al., 1999), 
glial fibrillary acidic protein (Gomi et al., 1995; Pekny et al., 1995), neurofilaments (Elder et al., 1998a; 
Elder et al., 1998b; Rao et al., 1998; Zhu et al., 1998)  and lamin A (Sullivan et al., 1999), had 
suggested that IF proteins may not be required during embryogenesis. Therefore, it was hypothesized 
that the primary defect in the keratin type II null mutants would manifest in the epithelial cells that 
normally express keratins like those of the yolk sac and the extra-embryonic tissues like the trophoblast 
cells.  Mice that lack K8 (Jaquemar et al., 2003), both K18 and K19 (Hesse et al., 2000) or both K8 and 
K19 (Tamai et al., 2000) fail to form keratin filaments in simple epithelial cells, such as trophoblast cells. 
As a result, mutant embryos die between E9.5 - E10.5 owing to compromised trophoblast cell integrity, 
which leads to placental site hemorrhages that are particularly associated with trophoblast giant cells. 
However, despite a compromised keratin cytoskeleton, neither mechanical disruption of the trophoblast 
cells nor placental hemorrhage was seen in the keratin type II null mutants analysed here.   
The keratin type II null mutants died at E9.5 owing to a failure to form a fully functional feto-
maternal interface. They lacked a functional labyrinth. However, the defect in the placental labyrinth 
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alone may not fully explain the growth retardation and lethality of keratin type II null mutants.  A number 
of other mouse mutants with lethality at the same stage and very similar placental defects exhibit only 
mild or no growth retardation, such as embryos lacking  a basic helix-loop-helix transcription factor - 
Mash2, zinc finger transcription factors - Gata2 & Gata3, or Ets family transcription factor - Ets2 
(Guillemot et al., 1994; Ma et al., 1997; Yamamoto et al., 1998). The development of embryos during 
early organogenesis (E8.5 to E11.5) is critically dependent on the formation of a functional yolk sac 
circulation. The yolk sac consists of an outer endoderm and inner mesoderm layer, where keratins K8 
and K18 are expressed in the former layer (Hesse et al., 2000). At E7.0, blood islands (lined with 
endothelium) are formed between the endoderm and mesoderm. These fuse to form a primary vascular 
plexus (vasculogenesis), which then undergoes remodeling (angiogenesis) to produce an extensive 
vascular network. At ~E8.5, the yolk sac vasculature fuses with the embryonic vasculature, and until the 
chorioallantoic placenta is established, the yolk sac functions as a primitive placenta. Cessation of blood 
flow within the yolk sac plexus causing fetal growth retardation have been reported in embryos lacking 
HNF4 or trombomodulin (Chen et al., 1994; Healy et al., 1995).  In addition, a defect in the yolk-sac 
blood circulation is often associated with the dilation of the pericardium as an indication of osmotic 
imbalance within the embryo. In accordance, a few keratin type II null embryos at E9.5, exhibited an 
enlarged pericardium. Embryonic vascular development is initiated from the hemangioblast, a progenitor 
cell that also gives rise to primitive hematopoietic cells (Choi et al., 1998). It must be first assessed if 
keratins are expressed in the mesodermal layer of the yolk sac membrane that gives rise to the 
vasculature in the mouse embryo, given that traces of K8, K18 and K19 have been reported to be 
expressed in some blood vessels in the umbilical cord of humans (Jahn et al., 1987). Future work will 
assess whether the loss of type II keratins is associated with defects in primitive erythropoiesis by an 
indirect immunofluoresence staining using a Ter119 antibody, which identifies erythroid cells within the 
blood islands. Defects in vascular remodeling can be estimated by characterizing the expression of 
endothelium specific receptor tyrosine kinase, tie-2/tek (Dumont et al., 1994; Sato et al., 1995) and its 
ligand angiopoietin-1 (Suri et al., 1996), both of which are prerequisites for embryonic angiogenesis. 
These experiments are underway and have not been reported here due to the shortage of embryos 
during the time this discussion was written.  
Since the vascular defects in the yolk sac manifested before the labyrinth placenta became truly 
functional, it can be concluded that the vasculogenic and angiogenic defects in the yolk sac are the 
initial cause for the embryonic death of the keratin type II mutants.   
Mutation of genes belonging to the Notch signaling pathway like Notch1/Notch4 (Krebs et al., 
2000), delta-like4 (Duarte et al., 2004), Hey1/Hey2 (Fischer et al., 2004) and Rbpsuh (Krebs et al., 
2004) have been identified to block chorioallantoic branching. These genes are expressed within the 
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allantoic mesoderm/blood vessels, suggesting that the fetal vasculature may be important for initiation of 
branching of the chorioallantoic interface. However, in humans, chorionic villi develop before becoming 
vascularized (Castellucci et al., 2000). Hence, it is possible that the development of the labyrinth layer 
and vascularization may not be inter-related. It can therefore be concluded that the keratin type II null 
mice die due to two structural and functional defects. Firstly, altered angiogenesis and vasculogenesis 
in the yolk sac which manifests around E7.0 - E8.0 and secondly, due to a reduced feto-maternal 
interface with a dramatic reduction in the size of the labyrinth.   
The concept of epithelial-mesenchymal interaction, and the fact that keratins are expressed in 
epithelia and not in mesenchymal cells, opened a new dimension to analyzing the phenotype of the 
keratin type II null mice. Could altered mesenchymal-epithelial interactions account for embryonic 
lethality in keratin type II null mice? 
The major components of the mammalian placental membranes are made up of an epithelial 
surface layer- the trophoblast, and a heavily vascularized mesenchyme - the allantoic mesenchyme. 
The trophoblast layer makes the most intimate contact with maternal tissues and it displays a wide 
range of unusual, often invasive, phenotypes. However, one common feature of trophoblast 
development in all species is a strong correlation between the proliferation and differentiation of this 
epithelial layer and its physical contact with the developing allantoic mesenchyme. This strongly 
suggests an epithelial–mesenchymal interaction involving paracrine signals from allantoic mesenchyme 
acting on adjacent trophoblast (Lacey et al., 2002; Stewart, 1996). One such paracrine signal is the 
hepatocyte growth factor (HGF), which is a multipotent mitogen, morphogen and motility factor.  HGF is 
secreted as an inactive heparin binding glycoprotein, which remains in this form in the extracellular 
matrix. The biological actions of HGF are mediated via a transmembrane glycoprotein called c-met 
(Weidner et al., 1993).  Activation of c-met by hepatocyte growth factor leads to dimerisation of the 
receptor, followed by autophosphorylation of several intracellular messengers which are thought to 
mediate its subsequent effects (Somerset et al., 1997). The mitogenic properties of HGF include 
induction of c-met mediated cell division in many epithelial and endothelial cells, including trophoblast 
and vascular endothelium (Matsumoto and Nakamura, 1996; Zarnegar and Michalopoulos, 1995).  
During mesenchymal - epithelial cell interaction, HGF and c-met localize to the same cell types, induce 
paracrine signals and initiate proliferation, invasion, and organizing branching tubules (Somerset et al., 
1997). Analysis of HGF -/- embryos revealed that the mesenchymal cells of the allantois produce HGF, 
which acts as a paracrine growth factor on the epithelial derived labyrinthine trophoblast cells, via c-met, 
to aid normal labyrinthine development (Uehara et al., 1995). Several cytokines and growth factors are 
known to influence trophoblast migration [e.g. EGF (Wright et al., 2006), IGF-2 (McKinnon et al., 2001), 
HGF (Lala and Chakraborty, 2003)], proliferation [e.g. interleukin (Paiva et al., 2007), leptin (Magarinos 
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et al., 2007), HGF (Somerset et al., 1998), GM-CSF (Lea and Clark, 1993)] and/or invasion [e.g. LIF 
(Poehlmann et al., 2005)], each factor utilizing at least one pathway for intracellular signaling in the 
trophoblast. 
In agreement with epithelial-mesenchymal interactions playing a role in placental development, 
analyses of the keratin type II null embryos was carried out. In situ hybridization suggested that 
differentiation of the epithelial or mesenchymal layers were not affected.  The different trophoblast cell 
layers within the chorion are thought to give rise to the three layers of differentiated trophoblast in the 
mature labyrinth. Emerging data of gene expression and cell lineage tracing studies supports this model 
(D. Simmons et al, unpublished data). Detailed ultrastructural studies in the mouse (Hernandez-Verdun, 
1974) and hamster (Carpenter, 1972) placenta, as well as cell lineage tracing studies (Anson-Cartwright 
et al., 2000; Basyuk et al., 1999) during early stages of labyrinth development suggest that the 
epithelium derived cells, which are committed to express Gcm1, give rise to the innermost syncytial 
layer closest to the fetal capillaries (SynT-II) (Fig. 6.1). By contrast, more apical trophoblast cells, that 
are committed to express SynA, gives rise to both the outer syncytial  layer (SynT-I) and the trophoblast 
giant cells lining the maternal blood sinusoids [sinusoidal trophoblast giant cells (S-TGCs)] (D.Simmons 
et al., unpublished data). Although these layers have independent cell lineage origins, it is likely that 
their development is inter-dependent as differentiation of SynT-II begins within a few hours after 
allantoic attachment (Carpenter, 1972; Hernandez-Verdun, 1974; Hernandez-Verdun and Legrand, 
1975), whereas differentiation of SynT-I cells begins ~24 hr later and after morphogenesis has begun 
(Carpenter, 1972) (Fig. 5.1).  Any process that would disturb the balance between proliferation and/or 
syncytial fusion would alter the integrity and function of the layer as a whole, which in turn may impair 
gas and/or nutrient transfer to the fetus as well as endocrine activities.  In the keratin null mutants, 
Gcm1 expression, which begins at E7.5 in the leading edge of the chorion, was normal.  However, the 
chorionic trophoblast derived SynA positive cells, although present from E8.5, did not proliferate and 
elongate to contribute to the formation of the labyrinth. They remained flat and did not take the prismatic 
shape as that of the wildtype (Fig.4.14g Vs Fig.4.14h). It has already been established that Syncytin is a 
target of Gcm1 (Yu et al., 2002).  It can thus be speculated that the Gcm1 positive cells might secrete 
paracrine signals which stimulate the proliferation of the SynA positive cells, thereby establishing 
epithelial-epithelial interaction, which eventually lead to the formation of the syncytiotrophoblast and 
labyrinth. A combined in-situ hybridization-immunohistochemistry of SynA and proliferating cell nuclear 
antigen (PCNA) or histone H3, would validate the proliferation defect of this specific subset of cells.  A 
detailed ultra-structural study would clarify if the formation of the SynTI layer is affected in the keratin 
type II null mutants, which would be the case if indeed the proliferation of the SynA expressing chorion 
trophoblast cells is altered. It has been reported that the stimulation of PKA signaling leads to an 
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increase of Gcm1 transcript levels, which maybe responsible for a concomitant increase of the amount 
of syncytin transcript (Knerr et al., 2005). Whether this signaling is altered in the keratin type II null 
mutants would require culture of ectoplacental cone explants from the mutants, stimulation of Gcm1, 
and study the expression of SynA.  These experiments should be succeeded by migration and 
proliferation studies, to identify if such a paracrine signal does exist, and to identify altered upstream or 
downstream targets of the PKA pathway. RNA array analysis would be required to identify 
transcriptional changes in the keratin type II mutants in contrast to the wild type embryos. 
 
 
 
 
 
 
 
 
 
Fig 6.1. Electron micrographs showing the structure of the maternal– fetal interface in the labyrinth layer of the mouse placenta. 
The fetal blood space (fet) is lined by endothelial cells (endo), whereas maternal blood (mat) lies in direct contact with specialized 
trophoblast cells called sinusoidal trophoblast giant cells (S-TGC). Two layers of syncytiotrophoblast (SynT) are readily distinguishable 
ultrastructurally modified from Cross JC et al., 2006. 
 
5.4. Altered cell signaling seen in the keratin type II null mutants 
 
The keratin type II null mutants were smaller than their wild type littermates.  This however, was 
not a consequence of proliferation defects. The mutant embryos as well as the extra-embryonic tissues 
showed comparable levels of proliferating cells with the controls. Moreover, the trophoblast giant cells of 
the mutants showed a slight increase in cell size when compared to that of the controls (Fig.4.13e) 
These results argue against the reported role of keratins in cell cycle control (Kim et al., 2006; Margolis 
et al., 2006). However, it has not been estimated if there is a general reduction in protein translation in 
the mutants. Metabolic labeling using [35S] methionine, followed by incorporation of radioactivity 
measurements or monitoring the mTOR pathway would strengthen the argument of the role of keratins 
in cell cycle control.  
Although the keratin type II null mutants showed an increased rate of apoptosis of up to three 
fold (Fig.4.13), this could not be attributed to the primary cause of lethality in the mutants as suggested 
previously in the K8 null mutants (Oshima et al., 2002).  The authors argued that the lack of keratins 
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rendered the embryo more susceptible to maternal TNF, and this was the primary cause of the lethality 
in the K8 null mutants at E 12.5.  However, a closer look at the keratin type II null mutants revealed that 
the apoptotic cells were not restricted to the epithelial type and that the rate of apoptosis correlated with 
the size of the embryo.  Smaller the embryo, larger was the number of apoptotic cells, and vice-versa 
(Fig.4.13).  This argues against the protective role of keratins against apoptosis as suggested earlier 
(Oshima et al., 2002), and implies that the increase rate of apoptosis seen in the keratin type II null 
mutants is a consequence of malnutrition.     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6.2. Putative signaling pathways during labyrinth formation. Certain cells within the chorion commit to express Gcm1 which are 
the branching checkpoints from E7.5. Gcm1 likely produces paracrine signals that are picked up by the SynA expressing cells within the 
chorionic trophoblast cells, which then begin to proliferate and elongate by E8.5, following chorioallantoic fusion. These two cell types 
eventually form the labyrinth where the fetal blood forms intimate contact with the maternal blood sinuses.  This stimulation is also 
mediated by cyclic AMP/protein kinase A (PKA) signaling. It is speculated that keratins also play a role in this paracrine signalling, 
eventually allowing the SynA expressing trophoblast cells to proliferate and elongate.  In the absence of keratins, these cells cease 
proliferation and hence remain flat, thereby failing to form a functional labyrinth.  Following branching initiation, various other factors are 
responsible for branching morphogenesis.  Egfr, epidermal growth factor receptor; Fgfr2, fibroblast growth factor receptor 2; Gab1, growth-
factor-receptor-bound protein-2-associated protein 1; Gcm1, glial cells missing 1; Grb2, growth-factor-receptor-bound protein; Lifr, 
leukaemia inhibitory factor receptor; Mek, mitogen-activated protein kinase; Met, met proto-oncogene; p38α, p38 mitogen-activated 
protein-α; Sos1, son of sevenless homologue 1 (Courtesy, Dr. Simmons). 
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Apart from the probable defective paracrine signaling in the keratin type II null mutants, the 
mutants also showed reduced levels of activated p38, indicating a downregulation of the p38 MAP 
kinase pathway.  Members of the p38 MAPK family, respond to pro-inflammatory cytokines and cellular 
stresses, and behave as pro-apoptotic signals. They are activated by serial phosphorylation and 
activation of upstream kinases (the MAPK cascade).  The reduced levels of activated p38 seen in the 
keratin type II null mutants is in strong disagreement of the role of keratins in protection against 
apoptosis (Oshima et al, 2002), since an upregulation of the activated p38 MAPK would have been 
expected.  This now places keratins in a pathway, independent of the apoptotic pathway.  
The phenotype of the keratin type II null mutants is strikingly similar to that observed in p38-α 
knockouts that die a day later (Adams et al., 2000).  These mutants were drastically reduced in size, 
showed decreased vasculature and a decreased feto-maternal interface. Alterations in upstream targets 
like MEK3/6 and downstream targets like ATF1 / CREB have to be monitored in the keratin type II null 
mutants. Mice lacking both MEK3 and MEK6, the two main p38-specific MAPKKs, are not viable, dying 
at midgestation with defects in the placenta and the embryonic vasculature, very similar to the keratin 
type II null mutants (Brancho et al., 2003).  A combined heterozygous ATF1 and a null CREB situation 
caused embryonic lethality in mice at E9.5 with a phenotype attributed to indistinguishable 
extraembryonic mesoderm-derived structures like amnion, allantois, and chorion (Bleckmann et al., 
2002). Keratin 8 is reported to have a p38 target site on S73 (Feng et al., 1999). Recent data has 
demonstrated that in stress situations, K8 becomes phosphorylated at S73 by p38 MAP kinase, and this 
phosphorylated state determines keratin organization, thereby placing p38-dependent signaling as a 
major intermediate filament-regulating pathway (Woll et al., 2007). Identifying altered upstream or 
downstream targets of p38 would be instrumental in identifying the role of keratins in the p38 MAP 
kinase pathway.  
 
5.5. Summarizing the keratin type II null mutants 
  
In summary, the constitutive deletion of keratin type II cluster has revealed a novel role of 
keratins beyond its well established structural functions. The keratin type II null mutants died at mid-
gestation around E9.5. Surprisingly, no cell fragility was observed in either the embryonic or extra- 
embryonic tissues in the absence of keratin filaments. The lethality of these mutants could be attributed 
to defective angiogenesis and vasculogenesis in the yolk sac succeeded by defective branching 
structures that form a feto-maternal interface, leading to nutritional deficiency in the embryos. In situ 
data revealed that type II keratins were not involved in the normal differentiation of various cell lineages 
during early embryonic development. The mutant embryos were smaller than their wild type littermates; 
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however, they did not suffer from general defective proliferation. A positive correlation between 
apoptosis and size of the mutants was observed. Apoptosis was moreover not restricted to epithelial 
cells, indicating that apoptotic cell death in the mutants could be attributed to a consequence of 
nutritional deficiency. It is hypothesized that altered paracrine signaling between epithelium in the yolk 
sac as well as in the placenta contributed to the structural defects of reduced vasculature in yolk sac 
and absence of labyrinth, eventually leading to death of the mutant embryos. Altered p38 MAP kinase 
signaling in the keratin type II null mutants has suggested a role for keratins upstream in this pathway. 
In light of the data presented here, the phenotypes of previous keratin null mutants have to be 
reconsidered. 
 
5.6. Potential of the keratin type II null targeting and future perspectives 
  
The early prenatal lethality observed in the keratin type II null mutants proves the importance of 
type II keratins during early embryogenesis. However, in order to understand the relative roles of type II 
keratins in the trophoblast versus embryonic lineages, and to accurately identify the cell lineage that 
lead to embryonic lethality in the keratin type II mutants, conditional deletion of keratins is required. 
Moreover, early embryonic lethality has also limited the evaluation of keratin type II gene functions at 
later stages of embryogenesis, during and after birth.  Given the diversity of cell origins that keratins are 
expressed, a comprehensive study of its function in a particular cell lineage is not possible.  
 Therefore, in order to circumvent these problems, and in order to identify the specific cell 
lineage that caused lethality in the keratin type II null mutants, mice were generated from the double 
targeted ES clones in cis, as already reported in the first part of the results.  These floxed ES cells were 
used to generate chimeras and consequently mice homozygous for the floxed keratin type II cluster. 
With such an invaluable tool, it is now possible to carry out conditional deletion of the keratin type II 
cluster in a tissue specific and spatially controlled manner. Using an epiblast specific Cre mouse line 
such as Sox2-Cre (Hayashi et al., 2002) or More-Cre (Tallquist and Soriano, 2000), will identify if 
keratins are required during early embryonic development. The use of lentivirus-mediated pol II-driven 
Cre recombinase for trophoblast specific gene knockout (Georgiades, et al., 2007) or VE-Cadherin-Cre-
recombinase for endothelial specific Cre activity in the yolk sac (Alva, et al., 2006) will further strengthen 
the hypothesis of this thesis.  Moreover, tracing migration of keratin null epithelial cells from a stem cell 
niche, studying tissue homeostasis, tumor metastasis, wound healing and additional settings offers very 
exciting areas of research awaiting exploration.  These studies will provide important insights into type-
specific keratin function and into the general significance for tissue-specific functions of other large gene 
families. 
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SUMMARY AND CONCLUSION 
 
Keratins are major cytoskeletal proteins of epithelia, organized in two large gene families of 28 
(type I) and 26 (type II) members spanning 1.2 Mb and 0.68 Mb of genomic loci, respectively. Their 
expression is tightly regulated in a pairwise and differentiation-related manner in epithelial tissues 
starting from the 2-cell stage during embryogenesis. Fertilized mammalian eggs and embryonic stem 
cells are devoid of keratin filaments, raising the question whether they may be involved in stem cell 
differentiation.  Studies from various keratin mutations leading to tissue fragility placed protection 
against mechanical stress as the primary function of keratins. Recent research has led to the hypothesis 
that keratins have major regulatory functions in cell proliferation, translation regulation, protection 
against apoptosis, organelle transport and regulation of signal transduction.  The overlapping 
expression of several type I and II keratins in most epithelia has generated functional redundancy, and 
therefore has presented a major obstacle towards the analysis of keratin function. This thesis has 
addressed the function of keratins during development by constitutively and conditionally deleting all 
type II keratin genes in mice, thereby eliminating all problems related to redundancy. This is the first 
reported deletion of a large gene family in mammals. 
The Cre/loxP system was adopted in order to flox the type II keratin gene cluster in mouse ES 
cells. This floxed allele contained all the type II keratins including the type I keratin Krt18, which is one of 
the first keratins to be expressed during embryonic development. Mice were generated from the floxed 
ES cells (for conditional deletion) as well as from the Cre expressed ES cells (for constitutive deletion), 
thereby carrying either the floxed or deleted keratin type II cluster, respectively.  This thesis, however, 
has dealt only with the constitutive deletion of the keratin type II cluster, while the conditional deletion of 
the cluster in tissues of adult animals is underway.  
Mice heterozygous for the deleted keratin type II cluster were inbred to generate keratin type II 
null mice.  However, no keratin type II null pups were recovered at birth.  Mutant embryos were smaller 
than their wild type littermates from ~E9.0, and died at mid gestation (E9.5).  Despite the absence of a 
keratin cytoskeleton, no cell fragility was found in contrary to many other individual keratin knockouts. 
This shows that the phenotype reported for previous keratin gene knockouts represents gain of toxic 
functions. No overt proliferation defects were observed in the mutants even around the time of death 
suggesting that no proliferation defects accounted for lethality. Mutant embryos did exhibit the expected 
formation of epithelial lineages during embryogenesis, indicating no apparent role of keratins during 
embryonic differentiation. Mutant embryos suffered from defective vasculogenesis and angiogenesis in 
the yolk sac, which are the most critical structures required to nourish the embryo, before the placenta 
can take over from E9.0.  Reduced vasculogenesis was accompanied by the loss of endodermal-
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mesothelial cell interactions. Moreover, the mutants failed to form an organized labyrinth and the 
spongiotrophoblast layer at E9.5, although the chorioallantoic attachment at E8.5 was normal. Following 
chorioallantoic attachment at E8.5, a subset of chorionic epithelial cells expressing Syncytin A, destined 
to commit to the branching morphogenesis, failed to elongate and inter-digitate to form a functional 
labyrinth, but rather remained flat. Elevated levels of apoptosis in non-epithelial cells were seen in 
smaller mutant embryos in comparison to the fairly larger mutants and the wildtype embryos, suggesting 
a positive correlation between the two. This indicated that apoptosis was not a direct consequence of 
the absence of keratins but a secondary effect due to nutritional deficiency.  Unexpectedly, increased 
apoptosis did not elevate the pro-apoptotic signal transducer p38 MAP kinase.  Infact, a reduced level of 
activated p38 MAP kinase was observed in the mutants.  In agreement, the phenotype of the keratin 
type II null mutants showed a striking similarity to that observed in p38-α knockouts, although they died 
a day later than the keratin null mutants.  
The observations in this study have revealed major roles of keratins in epithelial-endodermal 
interactions and cell signaling.  Lack of cell fragility in the absence of keratins suggests that mechanical 
support cannot be considered as their primary function, at least during embryonic development. 
Therefore, knockouts of individual keratins reported so far, represent dominant-negative, but no loss-of-
function, mutations. It further questions previously reported roles of keratins in cell cycle, translational 
control and apoptosis. Keratins seem to mediate cell signaling, for which their topological organization 
within a cell is well suited. The data from the keratin type II null mutants suggests that keratins play a 
role upstream of the p38 MAP kinase pathway. The potential of these mice will be exploited to a great 
extent in the future by generating cell lines free of keratins for various functional assays as well as 
conditionally deleting the cluster in a tissue specific and spatially controlled manner.  This will for the first 
time allow to study their role in tumor development and chronic diseases in genetically well-defined 
settings. 
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